Entities

Tom Richards is an operating partner on 7wire Ventures’ current public team. The firm’s 2023 fund-close announcement describes him as formerly senior vice president and global lead of strategy and business development at The Cigna Group. His background supports portfolio-company development and healthcare commercial strategy; his Cigna role is historical rather than presumed current employment. The manager’s own 2023 fund announcement supplies his explicitly named authentic portrait. No Cigna corporate check or Richards personal investment is inferred from the affiliation.

David Schonthal is a 7wire Ventures operating partner with entrepreneurial, investment and design experience in healthcare. His current firm biography identifies Kellogg professorship and entrepreneurship-program leadership, co-founding healthcare innovation centre MATTER, and a global-adviser affiliation with Design for Ventures. Earlier he worked at IDEO, Pritzker Group Venture Capital and Tavistock Life Sciences. His work on resistance to innovation is reflected in the book The Human Element. His education includes a Kellogg MBA and Boston University BA.

iOrganBio, Inc. develops AI-guided manufacturing technology for human cells and organoids used in disease modeling, drug discovery and cell-therapy development. Its CellForge platform combines predicted cell states, biological measurements and automated three-dimensional incubation to control stem-cell differentiation. Genomic, transcriptomic and proteomic feedback informs changes in culture conditions as cells develop toward a partner’s specified biological profile. The resulting cells are delivered with process and endpoint data for comparison against the requested target. CellAtlas supplies digital reference profiles of adult human cells and tissues, helping partners define target cell properties and benchmark laboratory-produced material. The company is developing reproducible, scalable alternatives to manually optimized cell-production methods, including human-relevant models for pancreatic and neurological applications. Its scientific advisers include specialists in human neuronal function and neurodegenerative disease models. Founded in 2024 by Daniel Delubac, Shuibing Chen and Xiling Shen, the company builds on stem-cell differentiation research originating at Weill Cornell Medicine. Its current website lists a Morrisville, North Carolina address; earlier releases describe its Chapel Hill BioLabs location.

Alyssa Jaffee is a 7wire Ventures partner investing in digital healthcare and technology-enabled services. Her primary biography identifies a NOCD board role and board-observer affiliations with several portfolio companies. Earlier she invested at Pritzker Group Venture Capital and worked at Hyde Park Angels, Healthbox and the Advisory Board Company. She co-founded TransparentCareer and holds a University of Wisconsin-Madison undergraduate degree and University of Chicago Booth MBA. These professional affiliations do not establish individual investment allocations.

Biotechnology entrepreneur with previous roles at Guardant Health, Freenome and Chemify. Co-founded iOrganBio in 2024 to apply engineering and automation to human-cell manufacturing.

Life-sciences entrepreneur and investor who co-founded GRAIL and Initiate Ventures. Previously worked on Kleiner Perkins’ life-sciences investment team.

Operations executive with prior portfolio-operations leadership at QHP Capital and strategic-finance and established-brands roles at Azurity Pharmaceuticals.

Weill Cornell stem-cell scientist and iOrganBio co-founder. Research from her laboratory underpins the company’s cell-differentiation technology.

Biomedical researcher and iOrganBio co-founder whose published affiliations include MD Anderson and the Terasaki Institute for Biomedical Innovation.

Rutgers neuroscientist researching human neuronal function, synaptic biology and neuropsychiatric and metabolic disorders. Leads the Rutgers Health Center for NeuroMetabolism.

Robert Garber is a partner at 7wire Ventures, which announced his promotion to managing partner in August 2024. He invests in digital-health businesses and currently lists board roles at GroundGame.Health, Homethrive and When Insurance. Earlier he led investments at Stratus Ventures and KB Partners and held operating, business-development and finance responsibilities at technology businesses. His education includes a Kellogg MBA and University of Pennsylvania BA. Published managed assets and executive transaction totals are career context rather than cash raised by a particular fund.

Lee Shapiro co-founded 7wire Ventures and serves as a partner. The firm’s biography describes his earlier work as Livongo CFO through November 2020 and Allscripts president from 2001 to 2012, including healthcare-company operations, business development and strategic transactions. He holds a University of Chicago law degree and a University of Illinois accounting degree. The current manager homepage names him American Heart Association board chair, superseding the older biography’s chair-elect wording. Override independently publishes his named JD portrait and board/investor affiliation; exact personal cash participation is not inferred.

Celine Gauchey is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Justin Bhandari is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Kshiteej Prasad is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Pranav Balan is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Topaz Aharon is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Azan Zahir Virji is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Brendan Johnson is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Carina Tyrrell is a physician-scientist and Black Opal venture partner. The firm describes Cambridge medical and public-health training, University of Cambridge and Cambridge hospital governance affiliations, Goldman Sachs analysis and investor/chief-of-staff work at Walden Catalyst. Outside appointments are retained as issuer-published career context.

Eve Castel is a Black Opal venture partner whose embedded biography specifies a sustainability focus. It identifies private-markets consulting, investment-banking experience at Morgan Stanley and education at Cambridge and London Business School. She is presented with the CFA designation.

Renee Lamb is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Sandy Uwimana is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Vanessa Stephens is named in Black Opal Ventures’ published fellowship roster. The programme supports investment sourcing, due diligence, sector research and developing investment theses with mentoring from the firm. This is a source-scoped fellowship affiliation; its cohort dates, full-time employment and individual investment authority are not independently disclosed.

Eileen Tanghal co-founded Black Opal Ventures and is a managing director. She studied electrical engineering and computer science at MIT and earned an MBA at London Business School. Her career includes semiconductor engineering, Applied Materials venture investing, Arm and In-Q-Tel. Current SEC filings also identify her as a manager and member of the advisory LLC. Her earlier investments at other firms are distinguished from Black Opal holdings.

Hanna Edgren is Black Opal’s chief of staff and venture analyst. Her published background includes marketing and corporate-development work at Bind Benefits, strategy work involving Health Tech Nerds and McGill University education.

Justin Craib-Cox leads investments at Black Opal Ventures. The firm’s embedded biography identifies convertible-bond portfolio-management experience and education at London Business School and the University of Virginia. He is presented with the CFA designation.

Karthik Ramasubramanian is a Black Opal venture associate. The firm identifies prior healthcare consulting at ZS, undergraduate study at Stanford and an MBA at the University of Michigan.

Simon Segars is a Black Opal executive adviser. Its biography identifies his earlier tenure as Arm’s CEO and published board affiliations at Vodafone and Dolby. The adviser role is distinct from an investment-team employment or a personal investment allocation.

Tamra Lair is listed as Black Opal’s industry adviser, while her embedded biography also identifies investment-committee service. It describes analytics leadership at Bind, healthcare analytics work at Mercer and IBM Watson Health, and a senior-partner affiliation with Measure Forward Partners. These are published career affiliations rather than independently verified new appointments.

Tara Bishop co-founded Black Opal Ventures and is a managing director. She trained in chemical engineering at MIT, medicine at Cornell and public health at Mount Sinai. Her career includes clinical leadership at Surest/Bind, healthcare work at McKinsey and health-policy teaching at Weill Cornell. Current SEC filings also identify her as a manager and member of the advisory LLC.

Black Opal Ventures is a healthcare and frontier-technology venture-capital firm co-founded in2021 by physician Tara Bishop and technology investor Eileen Tanghal. The exact New York advisory manager is Black Opal Ventures LLC, CRD322153, SEC exempt-reporting-adviser file802-126325; its directly retrieved annual FormADV is datedMarch23,2026, which supersedes the older March2025 indexed version. The manager, separate fund partnerships and GP companies are distinguished rather than represented as duplicate institutional buyers. The current public team lists five operating/investment staff, an executive adviser, an industry adviser and four venture partners; its separately published ten fellows are programme affiliations, not assumed full-time employees. The mandate spans AI-enabled healthcare, diagnostic and neurological technology, techbio, compute/infrastructure and security. Source-identified Black Opal investments include Empatica, Optellum, Hyro, Outpace, TigerGraph, AuthMind, Parasail, FlyteHealth and Isaac Health; the founders’ pre-Black-Opal Cerebras, Twist Bioscience, Sequans and Paragraf investments are expressly distinguished. The issuer’s2023 announcement said58MUSD raised to date while fundraising continued, not a final58M corpus. A laterAugust2024 SEC amendment reports its exact FundI partnership fully sold at62,665,000USD with zero remaining, including57,540,000USD from the earlier506(b) offering; those prior sales are included rather than added again. Exact final closingday is undisclosed. The current FundII PrimaryFund LP was formed in2026; itsAugust7,2026 FormD reported zero sold and firstsale yettooccur against an indefinite offering, so no fundraise target or actualcorpus is invented. Privatefund GAV/AUM and LP organisational capital are not treated as fundraising closes. Isaac Health’s primaryAugust14,2025 SeriesA explicitly names Black Opal as a new participating institution, with individual allocation and subscribing fund unpublished. The public roster’s advisers and fellows, outside positions and dated career affiliations do not create personal investment checks.

PACE Healthcare Capital is a Chicago venture capital firm investing in digital-health and healthcare-technology businesses that improve care outcomes and reduce costs. It backs companies with commercial traction at late seed, Series A and Series B, including software, artificial intelligence and machine-learning products. Its published strategy excludes medical-device and life-sciences investments, and targets initial investments of USD1m–4m with follow-on capital. The firm supports founders with healthcare operating experience, commercial networks and financial guidance. The PACE brand is tied to legal adviser PACE Healthcare Capital Management, LLC through its official FormADV website, address and leadership disclosures.

April E. Evans is a private-equity and venture-capital finance executive whose experience includes Monitor Clipper Partners and Advanced Technology Ventures. PACE publishes her as Partner and CFO; its March2026 official adviser report names April Elizabeth Evans as Chief Financial Officer and Chief Compliance Officer of the PACE legal manager. No additional outside-company role is inferred.

Derek Robinson is a physician executive with experience in medical leadership, healthcare quality and patient safety. His career includes HCSC, Blue Cross and Blue Shield of Illinois and the Centers for Medicare and Medicaid Services.

E.J. Reedy builds entrepreneurial communities connecting science, technology, healthcare and capital. His previous work includes Portal Innovations, the University of Chicago’s Polsky Exchange and the Kauffman Foundation. The issuer publishes initials only; they are preserved.

Ellen A. Rudnick is an entrepreneur and healthcare-business executive whose experience includes the University of Chicago’s Polsky Center, Healthcare Knowledge Resources, HCIA and Baxter. She has served on corporate and nonprofit boards.

James H. Mutchnik is an antitrust and white-collar defence lawyer whose work includes competition litigation and merger matters. The PACE biography describes him as a retired Kirkland & Ellis partner.

Jon David Willingham develops and finances businesses and advises investment firms on growth and governance. His experience includes Highmore, Starwood Energy Group and VantagePoint Capital Partners.

Julia Monfrini Peev founded PACE Healthcare Capital after investing in healthcare at CDPQ and Monitor Clipper Partners. She began her finance career at Merrill Lynch and trained at Harvard Kennedy School and ESCP.

Kate Wolin is a digital-health entrepreneur and behavioural epidemiologist who founded ScaleDown. Her career includes product leadership at Optum, corporate health services and entrepreneurship teaching.

Kevin Klauer is an emergency physician and healthcare executive whose experience spans hospital-based services, medical organizations, patient safety and clinical risk management. PACE publishes him as a senior adviser; outside positions in its undated biography are not independently asserted as current.

Ling Kung works at the intersection of healthcare strategy, technology and service design. Her experience includes payer-provider innovation, Medicare strategy and consulting at PricewaterhouseCoopers.

Manmit Bhambra advises PACE on diversity, equity and inclusion. Her research and consulting experience includes sociological change, policy and organizational inclusion, with training at Oxford and the London School of Economics.

Maria Siambekos has led healthcare software and service businesses and worked on clinical technology and operations. Her career includes ArborMetrix, Champion Healthcare Technologies, Vynca, Healthbox and GE Healthcare.

Michael R. Williams brings healthcare operating and startup experience from BMS, Pfizer, Takeda and MATTER’s venture acceleration program. He helps digital-health entrepreneurs develop their businesses.

Nans Rivat worked in investment banking at Goldman Sachs and HSBC before his investment role at PACE. His experience includes financial-sponsor coverage and entrepreneurship.

Vanessa Rollings Giannis is a finance executive with experience helping healthcare and technology businesses raise capital and build finance teams. Her earlier positions include CFO of Tempus AI and investment banking at William Blair.

Waverly Deutsch teaches entrepreneurship and venture creation and has served on startup advisory boards. Her career includes Chicago Booth and Forrester Research.

Jordan Wan founded CoFound in late2019 and is its general partner. An MIT-trained software engineer, he worked at Bridgewater Associates and healthcare technology businesses including Zocdoc, Oscar Health and PayPerks before founding the go-to-market recruitment business now known as Formative. CoFound’s current own biography describes his work on pricing, customer acquisition and early enterprise sales. Current CoFound is distinct from that recruitment company. A first-person2026 statement says he stepped back from Formative to focus on CoFound; older recruitment CEO titles are not assertedcurrent.

Libby Fidel is CoFound’s investor focused on deep technology and AI, publicly welcomed as its first investor hire on July1,2026. Her background includes investing and company building at Roadrunner across advanced manufacturing, compute, energy and quantum, healthcare advisory work at CBRE in London, and reimbursement/pricing analysis at Cloudmed. She graduated with honours in biology and an evolutionary-medicine minor from UCLA. Her own current biography places her in SanFrancisco; the role does not establish any personal investment.

CoFound Partners, also presented by its current own site as CoFound and named Co-Found Partners in IsaacHealth’s2024 seed announcement, is an early-stage venture investment platform launched by Jordan Wan in late2019. It backs technical founders in software, healthcare and deep technology while helping with customer discovery, pricing, sales and product-market fit. Its current team includes founder/general partner Jordan Wan and investor Libby Fidel, whose focus covers deep tech and AI. Libby’s own appointment announcement is dated July1,2026; both current public named team members are recorded with genuine individually attributed portraits. Third-party extra adviser/headcount claims are not treated as a current published roster. The exact cofoundpartners.com platform is distinct from similarly named cofounder studios, cofound.com and general founder partnerships. Its primary March31,2026 FormADV identifies the Delaware legal adviser CoFound Ventures Management, LLC, CRD315294, alongside related CoFound fund/GP entities. The current platform identity is linked by those exact legal filings and its named founder; neither a concept-fund LLC nor a fund-specific GP is silently substituted as the paying subscriber for every portfolio investment. Isaac’s precise subscribing fund/SPV and individual ticket remain unpublished. Formative/CloserIQ is Jordan’s separate recruitment-business history, not a duplicate fund manager. Three exact primary legal vehicles are captured: CoFound Partners, LLC (the2019 concept vehicle), CoFound Partners Venture Fund I, LP (formed2021) and FundII, LP (formed2024). The concept vehicle’s April6,2021 amended FormD reports USD2,000,100 total offered and sold, with zero remaining: an actually fully subscribed offering as of that filing, not a target or incremental extra raise. FundI’s June2022 filing reported10.688M sold-to-date; the manager’s October24,2023 retrospective announces its15M institutional fund. The later15M corpus supersedes that earlier partial snapshot rather than being added to it; exact final closing day is unpublished. FundII’s initial January2025 filing had zero sold before its offering progressed; no later actual corpus is proven. ADV private-fund asset values are investments/valuations, not new LP subscriptions or confirmed corpus. Actual source-proven backing includes IsaacHealth’s USD5.7M Jan29,2024 seed, CoFound’s reported participation in Destro’s USD8M Sep29,2026 seed and its lead of Coverwatch’s USD4.5M Jul23,2026 inception financing. The manager’s own AngelList syndicate material also lists ChartHop, GarnerHealth, NCX, GrowTherapy, Tilled, Almanac and SiteRX, without allocating exact tickets or investment days. Missing and sparse relevant portfolio companies are queued for full primary issuer audits. The sole Isaac issuer owner adds its exact institutional participation; the manager profile does not invent personal founder checks, unknown paying vehicles or duplicate issuer cash rounds.

David Hahn is CISO Operating Partner at Ballistic Ventures. His career includes security leadership at Silicon Valley Bank, Wells Fargo, CDK Global, Intuit and Hearst and advice to cybersecurity startups. His published profile also describes CISO advisory work at Fortinet. He holds an MBA from Golden Gate University and studied at San Jose State University.

Michelle Kincaid is Vice President of Marketing and Platforms at Ballistic Ventures. She helps portfolio businesses with communications, brand development and go-to-market work. Previously she led communications and customer marketing at network-observability and security company Kentik and reported on cybersecurity as a freelance journalist in Washington, DC.

Sue Barsamian is an external adviser to Ballistic Ventures. Her career combines enterprise software and cybersecurity operating leadership with board work for public and private technology companies. She previously led sales and marketing for HPE Software and Hewlett Packard’s enterprise cybersecurity business and held go-to-market and marketing posts at Mercury Interactive and Critical Path. Portfolio board affiliations in the published biography are not automatically recreated as current roles.

Kevin Mandia is a co-founder and General Partner at Ballistic Ventures. He founded Mandiant and served as its CEO from 2016 to 2024, including its acquisition by Google in 2022. His earlier cybersecurity career includes Sytex, Foundstone and computer-security and investigations work in the US Air Force. He holds computer-science and forensic-science qualifications from Lafayette College and George Washington University.

Nicole Perlroth is a Venture Partner at Ballistic Ventures and leads cyber-focused investment work at Silver Buckshot. She previously covered cybersecurity for The New York Times and wrote This Is How They Tell Me the World Ends. Her published career includes cybersecurity policy-advisory work, teaching and public communication. She studied at Princeton and Stanford.

Jake Seid is a co-founder and General Partner at Ballistic Ventures. He previously founded Stone Bridge Ventures and was president of the Ten-X/Auction online real-estate marketplace. His earlier career includes the launch and investment leadership of Lightspeed Venture Partners and product work at Cisco. He holds electrical-engineering and computing qualifications from MIT.

Agnes So is Chief Financial Officer at Ballistic Ventures and has supported its finance and operations since 2021. Her earlier career includes auditing at Deloitte and venture-capital finance work at Kleiner Perkins and Westlake Village BioPartners. Her current role leads the firm’s financial and internal operating functions.

Adrian Mallinger works in Operations and Administration at Ballistic Ventures. Her published professional biography describes more than fifteen years supporting venture-capital partners and portfolio-company chief executives. Her work focuses on organisational support and coordination for investment teams and company leaders.

Caroline Salas works in Operations and Administration at Ballistic Ventures. Her earlier career includes public-relations sales at Dolce & Gabbana, opening and operating SoulCycle locations and work at AlienVault and AT&T Cybersecurity. Her professional experience combines operating coordination and relationship management.

Jaime Blasco is an external adviser to Ballistic Ventures and co-founder and CTO of Nudge Security according to his published firm biography. He previously led threat intelligence and data science at AT&T Alien Labs and served as chief scientist of AlienVault before its acquisition. He helped establish the Open Threat Exchange community and works on threat research and collaborative intelligence.

Marcus Bragg is an external adviser to Ballistic Ventures. His career focuses on SaaS growth, sales, marketing, product alignment and customer success. He previously served as COO at Netlify and AlienVault and held sales and customer-success leadership at Zendesk and RightNow Technologies. The firm’s published biography describes independent board work at Concentric.ai and conversational-AI company Quiq.

Tim Eades is an external adviser to Ballistic Ventures. His career includes chief executive roles at vArmour, Silver Tail Systems and Everyone.net and executive posts at BEA Systems, IBM, Phoenix Technologies and Sana Security. His published biography describes mentorship and investment experience in cybersecurity and enterprise software; the advisory listing alone creates no personal cash check.

Marshall Heilman is an external adviser to Ballistic Ventures with experience in cybersecurity practice, executive leadership and company operations. He formerly held the global CTO role at Mandiant and worked across consulting, threat intelligence, malware analysis and managed detection and response during its growth and acquisition by Google. His earlier career includes networking and red-team work in the US Marines. Current portfolio operating responsibilities require issuer confirmation rather than an inferred board role here.

Andy Johnson is an external adviser to Ballistic Ventures. His professional background includes leading acquisitions for HP Software and serving as CFO of AT&T Cybersecurity and AlienVault. His published profile identifies finance leadership at threat-intelligence business Constella Intelligence and experience in transaction analysis, execution and integration. He is not inferred to be another person named Andy in life-sciences profiles.

Raffael Marty is an external adviser to Ballistic Ventures. His cybersecurity experience includes research, engineering, analytics, investing and corporate strategy. He previously led cybersecurity management at ConnectWise, research and intelligence at Forcepoint and security analytics at Sophos. He founded analytics businesses PixlCloud and Loggly and held roles at IBM Research, ArcSight and Splunk.

Holly Rollo is a go-to-market adviser in Ballistic Ventures’ external advisory network and leads SurgeStrategies. Her background spans marketing, positioning, product strategy and business transformation for cybersecurity and enterprise software companies. She previously held senior marketing roles at RSA/Dell Technologies, Fortinet and FireEye and worked at Cisco, SAP and other software businesses. She wrote Power of Surge.

Derek Smith is listed in Ballistic Ventures’ external advisory network. He founded technology companies including Oakley Networks, acquired by Raytheon, and Shape Security, acquired by F5. His career also includes mentorship and cyber-policy advice to the US Office of the Secretary of Defense. The current advisory listing supersedes the firm’s historical 2022 Incubation Partner launch designation for this profile’s current affiliation.

John Spiliotis is an external adviser to Ballistic Ventures with experience in technology sales and go-to-market operations. He previously led sales in the Americas at Palo Alto Networks and channel strategy at Avaya, with earlier positions at Cisco, Extreme Networks and Redback Networks. His published profile describes independent advice to venture-backed cybersecurity businesses and board service.

Kiersten E. Todt is an external adviser in Ballistic Ventures’ advisory network. She formerly served as CISA chief of staff and managed the Cyber Readiness Institute, which develops cybersecurity resources for small businesses. Her career includes federal legislative and cybersecurity-policy work and advice on data provenance, AI risk, open-source software and cyber risk. Agency and government operating posts are described as historical unless independently current.

Phil Venables is a Venture Partner at Ballistic Ventures. His current firm biography describes early-stage cybersecurity investment work, senior advisory work with Warburg Pincus and strategic security advice to Google. He previously served as Google Cloud’s first CISO and held long-running security and operational-risk leadership posts at Goldman Sachs. His published education covers computer science, formal methods and cryptography at York and Oxford.

Chris Inglis is an external adviser to Ballistic Ventures. He served as the inaugural US National Cyber Director from 2021 to 2023 and previously as NSA deputy director and chief operating officer from 2006 to 2014. His career includes the Cyberspace Solarium Commission, teaching at the US Naval Academy, investment and board advisory work, and Air Force and Air National Guard service. His engineering and computing qualifications include Columbia, Johns Hopkins and George Washington universities.

Katie Glenn works in Operations and Administration at Ballistic Ventures. Her prior career includes supporting chief executives, presidents and boards at eBay, Varian Medical Systems and Auction.com. Her experience centres on executive support, stakeholder coordination and organisational administration.

Jim Routh is an external adviser to Ballistic Ventures. His security leadership career includes American Express, CVS Health, JPMorgan Chase, KPMG, MassMutual and Aetna. He formerly chaired the Health Information Sharing and Analysis Center and served on the financial-services counterpart’s board. His published work spans security controls, data science, board advice and cybersecurity education.

Gregory Crabb is a CISO-in-Residence in Ballistic Ventures’ external advisory network. He previously led information security at the US Postal Service during a long law-enforcement career. He founded cybersecurity consulting firm 10-8 and advises organisations on protecting networks, digital assets and critical infrastructure.

Karen Correa is a CISO-in-Residence in Ballistic Ventures’ external advisory network. Her published professional background includes cyber governance, policy and risk-management leadership at FIS and an eighteen-year career at EY, culminating in principal-level security responsibilities. She advises on security programme design and emerging threats.

Frank Verdecanna is an external adviser to Ballistic Ventures, helping portfolio businesses with financing, financial models, budgeting and capital planning. He has held CFO posts at public and private technology companies and was executive vice president and CFO of Mandiant before its sale to Google. He retired from that operating role in February 2023 and subsequently pursued advisory and board work.

David Schellhase is an Entrepreneur-in-Residence listed in Ballistic Ventures’ advisory network. His background combines legal and operational leadership at technology companies, including general counsel work at Salesforce, Groupon and Slack, with responsibility for corporate transactions and public offerings. His published profile includes Okta board service and advice to Airtable and Webflow. This advisory affiliation does not establish full-time employment.

Julie Tsai is a CISO-in-Residence in Ballistic Ventures’ external advisory network. Her security and engineering career includes Roblox, Box and Walmart, with experience spanning application development, infrastructure, security architecture and DevSecOps. She studied at Stanford and advises on building and scaling security programmes.

Bonnie Komar is Controller at Ballistic Ventures. She joined the firm in 2025 after supporting it from 2022 through her work as a Standish Management manager. Her professional experience covers accounting, operations, reporting and venture-capital finance.

Punit Minocha is a strategic adviser in Ballistic Ventures’ external advisory network. His technology career includes corporate development, acquisitions, partnerships and growth leadership at Palo Alto Networks, Zscaler and Trend Micro. His most recent published operating role was executive vice president of business and corporate development at Zscaler. Ballistic announced his strategic-adviser appointment in July 2026.

Adam Bain is a current external advisory-board member of Hakluyt Capital. Its own directory identifies him as co-founder and managing partner of01Advisors and a former Twitter chief operating officer. Opendoor’s current director biography corroborates that investment career. The Hakluyt advisory position is not employee status or an inferred personal investment.

Varun Chandra co-founded Hakluyt Capital in2022 and served as its chairman. The manager’s own July2024 announcement explicitly says he stepped down from that position and from leadership of the wider strategic-advisory firm to join the UK government; his founding role is historical, and no exact departure day is inferred. Before Hakluyt he worked in investment and merchant banking. A UK government announcement dated January23,2026 appoints him the prime minister’s US trade-and-investment special envoy, providing later dated career context rather than a current Hakluyt role.

Somesh Dash is a current external advisory-board member of Hakluyt Capital, separately from its employee investing team. The firm identifies his experience as an IVP general partner; IVP’s own current directory confirms that role. The advisory affiliation alone is not a personal cash check or a direct role at Hakluyt portfolio companies.

Paul Dimitruk is a currently published member of Hakluyt Capital’s investment committee. He co-founded Partners Capital in2001. Its current own biography identifies him as vice chairman and explicitly confirms his continuing Hakluyt Capital investment-committee membership, while describing his Hakluyt parent directorship as former; this newer distinction supersedes the manager’s older senior-partner/parent-director wording. His background includes institutional investment leadership and legal practice at Gibson Dunn, with an NYU law degree.

Paul Deighton is a currently published member of Hakluyt Capital’s investment committee. His career includes Goldman Sachs, leading the London2012 Olympic organizing committee and serving as UK commercial secretary to the Treasury. The Economist Group’s current own board biography confirms his non-executive chair position there. His committee affiliation is recorded separately from employment in the investing team and does not assert a personal investment.

Gabrielle Davies is the operations director of Hakluyt Capital. She joined the wider Hakluyt platform in2016 and coordinates operational processes and engagement with leaders, partners and advisers. She previously worked in a London family office, for a former UK attorney general and for the London2012 Olympic organizing committee. Her education includes international politics and Cambridge business/project-management training.

Sammy Alkhatib is Hakluyt Capital’s investment director in San Francisco. His work covers sourcing, diligence and portfolio support, with a focus on AI labs, hyperscalers and financial sponsors. He joined Hakluyt in2021 following roles at Citi Ventures and Prudential Financial and holds a Georgetown business-school master’s degree.

Mitchell Harris is a partner at Hakluyt Capital based in London. Before joining Hakluyt in2021 he held biotechnology strategy and operating roles at Genomics plc and Abcam. He previously worked at McKinsey and AI business QuantumBlack and in the UK Cabinet Office on healthcare and life-sciences policy.

Adam Tarhouni is a partner at Hakluyt Capital working on origination, diligence and portfolio support. He joined the wider Hakluyt platform in2023. His prior work includes semiconductor and software strategy at Bain, early-stage investing at Sherpa Ventures, now ACME Capital, and corporate strategy at a Dubai-based energy company. He studied at Stanford and has also worked in Libyan public affairs.

James (Jamie) Potts is Hakluyt Capital’s current founding and managing partner, based in San Francisco and responsible for investment origination and relationships with venture funds and founders. His own biography explicitly bridges the James and Jamie names. He joined the Hakluyt platform in2018 after Goldman Sachs Asset Management and ten years in the UK Foreign and Commonwealth Office, including work in Syria, China and the United States.

Nick Bidmead, identified as Nicholas Bidmead in the fund’s SEC filing, is Hakluyt Capital’s currently published founding partner. Older2023/2024 announcements described him as managing partner; the current directory’s founding-partner title is retained here. His career includes technology diligence at Hakluyt, consulting at McKinsey, running an Apax-backed machine-learning business and European internet equity research at Donaldson, Lufkin and Jenrette.

Hakluyt Capital is the growth-stage technology investing business operated by Hakluyt Capital Limited, UK company09643506, distinct from the wider Hakluyt & Company strategic-advisory business. The legal company was incorporated June17,2015 as AGHOCO1320Limited and renamed Hakluyt Cyber Limited before taking its current name February11,2022. The investing initiative itself was created in2022 and publicly launched inMarch2023; the founding-year field records the legal corporation rather than implying a2015venture strategy. Its current own disclosure identifies it as an appointed representative of FCA-regulated Laven Advisors LLP, not independently authorised simply from that relationship. The firm co-invests alongside venture and growth managers in high-growth technology companies, historically targeting SeriesB toD. Its portfolio spans AI threat intelligence, AI healthcare workflow and care coordination, supply-chain analytics, autonomous drone delivery and enterprise software. It uses the wider Hakluyt network to support market entry, customer and adviser introductions and regulatory context. Strategic advisory engagements or introductions are not themselves equity investments. The current directory publishes six operating investment/operations people and two investment-committee members. Its separate current advisory-board directory publishes Adam Bain, Somesh Dash and Mamoon Hamid as external advisers. Matt Clifford is recorded only as confirmed in theJune2024inaugural board announcement; continuation is unverified because the current list omits him. Co-founder Varun Chandra’s chairman role is explicitly former after the manager’s July2024departure announcement. No adviser is assigned a personal check solely from these affiliations. Its first fund, Hakluyt Capital I LP, reached final close inJune2024 above its USD50M fundraising target; the exact final corpus and closing day are not disclosed in the primary closing announcement or fund counsel’s account. A March27,2024 SEC amendment reported USD28.525M sold at that filing snapshot, not the eventual global final corpus. The fund is a separate UK partnership founded2022, with Hakluyt Capital I GP LLP and Hakluyt Capital GP Limited identified as GP/designated-member entities. No separate bare legal shells or invented allocations are added. Genuine portrait gaps remain for current external adviser Adam Bain and historical founder Varun Chandra.

Gregory R. Hardester appears as a historical statutory manager and authorized signatory for AME-associated investment vehicles. In Vicarious Surgical’s September17,2021 registration-rights agreement he signs as Manager of AME Cloud Ventures LLC and AME Cloud Ventures Fund I LLC, and as Authorized Person for AME 2019 Fund LP through AME 2019 GP LLC. In the October29,2021 Neutron Holdings note-purchase agreement he signs for AME Cloud Ventures LP through AME Cloud Holdings LLC and for AME 2019 Fund LP. These transaction signatures establish historical legal capacities; a current employment title, investment-partner role and authentic portrait remain unverified.

Cathy Luu is listed as Operations Manager at AME Cloud Ventures, responsible for operations, events and portfolio support. Previously she spent nine years at Yahoo as a senior executive administrator supporting Jerry Yang. She earned a bachelor’s degree at San Francisco State University.

Nick Adams is listed as Venture Partner at AME Cloud Ventures, which he joined in 2012. AME explicitly states that he stepped back from investing in new companies in 2020 while remaining a venture partner. His areas of interest include automation, machine learning and software-defined infrastructure. Before AME he spent five years in China and India, led business development for Cloud Valley and founded two startups. He earned a master’s degree in engineering at Imperial College. The published role is preserved with its stepback qualification, without asserting an active current new-investment remit.

Wretch Chien is listed as Principal at AME Cloud Ventures, which he joined in 2014. His interests include aerospace, intelligent robotics and advanced medical devices. He founded Taiwan blogging service wretch.cc and led its growth before its acquisition by Yahoo. He earned an MBA at Stanford. AME names Capella Space, Accion Systems, Canvas Technology, MegaBots and Vicarious Surgical as selected portfolio companies. His card repeats Jeff Chung’s social links, so those misbound links are excluded.

Jeff Chung is listed as Managing Director at AME Cloud Ventures, which he joined in 2013. He invests in frontier technology and businesses shaped by data and machine intelligence, including biology, manufacturing and infrastructure. Before AME he invested in growth-stage technology companies at Silver Lake. He earned a bachelor’s degree at UC Berkeley and an MBA at Harvard. AME names Nervana Systems, Freenome, Elementum, Synthego and Rigetti among his selected portfolio companies. The directory’s outside Savioke board wording is older published context, not confirmation of a current 2026 appointment.

Michael Johns is named as a director of NeuroTrack Technologies, Inc. in its December2014 SEC FormD. That legal source establishes this historical company affiliation but does not independently bridge him to an unrelated academic, physician or investor namesake. The filing does not name him as the subscribing investor; no personal check or present directorship is inferred.

Michael Davis is the principal investigator recorded as MICHAEL NMN DAVIS on NIA award1R43AG047710-01 to Neurotrack Technologies, Inc., FY2014, for its cognitive-assessment research. The award identifies his research role without establishing executive employment, academic credentials or a personally allocated investment. This scoped identity is distinct from Michael Davis, the existing Questa Capital professional.

Asha Robinson-Parks, MD, is the family-medicine physician named in Neurotrack’s clinical advisory-board announcement1November2022. The issuer included external employer captions as context at publication; those are not assumed current outside jobs. This source-dated clinical advisory affiliation is separate from executive employment, a statutory company board seat and individual financing.

Feyza Marouf, MD, is the geriatric psychiatrist named in Neurotrack’s four-physician clinical advisory board announced1November2022. The primary issuer places her expertise in cognitive clinical care. The dated advisory role is distinct from a current employee or statutory directorship; no unverified external employer, substitute portrait or personal investment is adopted.

Meena S Makhijani, DO, is the UCLA geriatrician named in Neurotrack’s clinical advisory-board announcement1November2022. UCLA’s own provider page describes mechanical-engineering training at UC Berkeley, osteopathic medical education at Nova Southeastern, family-medicine residency and UCLA geriatric fellowship. Her clinical expertise supports this specific historical advisory identity; no current Neurotrack executive or personally allocated check is inferred.

Deborah Dittberner, MD MBA, is one of four physicians on Neurotrack’s clinical advisory board announced1November2022. The issuer then described her as an Aledade regional medical director. That outside title and company advisory appointment are historical publication context; a current executive job, statutory board seat or individual financing check is not inferred.

Nicholas Bott, publicly Nick Bott PsyD in Neurotrack’s2018 announcement, was its historical chief science officer. The2019 NIA notice names Nicholas Bott principal investigator for1R44AG063672-01. These company and award sources bridge the public/formal names; the current chief scientist is Russell Banks, so no present Bott employment is presumed.

Jordan Glenn is the Neurotrack research principal investigator on NIA annual notices for2020–2022 under AG063672. Older company scientific material describes him as chief science officer. He is absent from the current executive roster, which names Russell Banks; this historical research and science leadership affiliation is source-dated, without a presumed present company employment term or personal investment.

Cecelia Manzanares is named as a Neurotrack scientific co-founder in the company’s founding account and Emory’s technology-transfer success story. Emory identifies her among the licensed visual paired-comparison technology researchers. She is absent from the currently pictured executive roster; her scientific founding role is retained historically without an invented present executive appointment, degree or substitute portrait.

Elizabeth Buffalo is a Neurotrack scientific co-founder pictured by the company with a University of Washington School of Medicine affiliation. Emory identifies her among the researchers behind the licensed memory and visual paired-comparison technology. This is a scientific founding relationship, distinct from an assumed present company executive position or personally allocated venture investment.

Stuart Zola is a Neurotrack scientific co-founder pictured on its current company page. Emory’s technology-transfer account identifies his memory-research work and historical leadership of its primate research centre, and describes the visual paired-comparison science licensed to Neurotrack. His scientific founding affiliation does not establish a current statutory company executive job or personal funding check.

Marc Leighton is Neurotrack’s Vice President of Product, named and pictured on the current company page. His published affiliation concerns the company’s provider-facing cognitive assessment and care platform. No unverified prior employer, academic qualification or unrelated Leighton identity is inferred from the title.

Kaitlyn Williams is the Vice President of Customer Success on Neurotrack’s current company roster. Her role is associated with supporting healthcare customers adopting the company’s digital cognitive-screening and care workflows. The named original company portrait supports this identity without merging unrelated Williams profiles or asserting unpublished career credentials.

Dylon MacEachran is Neurotrack’s Vice President of Marketing, named and pictured on the current company roster. The affiliation concerns communicating its cognitive-screening and clinical care platform to healthcare organisations. Primary company material establishes this specific executive identity; unverified past employers, degrees and investment allocations are excluded.

Russell Banks, also called Russ Banks in Neurotrack’s authored scientific content, is the current Chief Science Officer pictured on its company page. Own2026 content identifies him as PhD. ADDF identifies him with the company’s multimodal cognitive-assessment research, separately from equity financing. His work concerns digital cognitive phenotyping and ageing; no unrelated Banks identity or presumed clinical licence is adopted.

Amanda Ivanovics is Neurotrack’s current Chief Growth Officer. Executive-search partner Kindred’s2026 appointment account identifies her prior SVP Sales & Growth role at Milliman MedInsight, growth leadership at Iodine Software and work at the Advisory Board Company. Neurotrack’s own roster and authored posts confirm her current digital-health growth affiliation. No unrelated identity or individual investment is inferred.

Jeff Magnusson is the Chief Technology Officer named and pictured on Neurotrack’s current company roster. His published role concerns technology for the company’s digital cognitive assessment and cognitive-care platform, including clinical workflow products. Current primary pages establish this executive identity and role; unrelated Magnusson biographies and unverified previous employers or degrees are excluded.

Elli Kaplan is Neurotrack’s co-founder and CEO on its current company roster. The company traces its2012 founding to her work with the scientific co-founders and her family’s experience of Alzheimer’s disease. SEC notices name her company president/CEO and director. Her affiliation concerns digital cognitive screening and clinical care workflows; no unrelated Kaplan identity or unverified academic credential is adopted.

Ben Silbermann co-founded Pinterest. Pinterest’s June2022 announcement records his transition from CEO to Executive Chairman, rather than an ongoing CEO appointment. His2025 ASU+GSV speaker biography identifies him as Pinterest Chairman and cofounder, founder of How We Feel and cofounder of Tambourine, with earlier Google work and a Yale degree. The Giving Pledge lists Ben and Divya Silbermann as joint2021 signatories. Synapticure’s February2022 seed announcement explicitly names “Ben and Divya Silbermann” together. Separate personal identities are recorded on that single company financing event with NULL individual allocations; the joint wording does not establish two separate paid tickets or a Pinterest corporate check.

Divya Silbermann is a philanthropist and founder of Tambourine, identified under that affiliation in Tipping Point Community’s current own board directory. The Giving Pledge lists Ben and Divya Silbermann as joint2021 signatories. Her own public professional post discusses Tambourine’s ALS research support; philanthropic programme commitments are distinct from direct company equity checks. Synapticure’s February2022 seed announcement explicitly names “Ben and Divya Silbermann” together as additional investors. Her personal identity is recorded alongside Ben on the one actual seed financing event with unknown individual allocation, without inferring a Pinterest or Tambourine corporate investment. An authentic self-published portrait was identified, but its public asset host returned403 and no uncertain substitute is used.

Gerald E. “Gary” Bisbee was a healthcare entrepreneur, author and investor. His2021 AJMC author biography identifies him as cofounder and CEO of Think Medium and host of healthcare-leadership interviews. His longtime collaborator David W. Johnson’s March14,2023 memorial records his death in2023 and career as cofounder of the Health Management Academy and Think Medium, including healthcare banking, academic and policy work. He earned a Wharton MBA and Yale doctorate in chronic-disease epidemiology. Synapticure’s February2022 launch identifies Gerald E. “Gary” Bisbee personally, with the historical Cerner affiliation, as a seed investor. This is the same healthcare leader memorialized under Gary Bisbee, not another similarly named individual; no current Cerner board appointment or corporate check is inferred.

Rohan Seth co-founded Clubhouse and Lydian Accelerator. His self-published Clubhouse profile and founder letter confirm the Clubhouse affiliation. Gold House’s name-bound profile describes his CTO/cofounder work, earlier Memry Labs venture acquired by Opendoor, product work at Opendoor and engineering on Google’s Android, Maps and location services. It lists a Stanford computer-science bachelor’s degree and a management-science-and-engineering master’s degree. His nonprofit’s own account describes Lydian Accelerator’s work to accelerate research for rare genetic diseases; this mission is not a claim of proven treatment. Synapticure personally names Rohan Seth, qualified by Clubhouse, as a seed investor; no Clubhouse corporate check is inferred.

Esplanade Ventures is a Canadian digital-health venture-capital firm with Toronto and Montreal offices, investing from seed through Series A and selectively Series B. Its current strategy favours healthcare AI software and companies commercialising in North America. The official portfolio includes Override, Neura Health, Sana Health, Cleerly, Rad AI and other healthcare and technology businesses; exit labels are preserved as historical. The firm’s own June 2021 announcement uses the Esplanade HealthTech Ventures brand and directly links the same esplanadeventures.com domain, establishing the brand bridge. It reports the inaugural Fund I closing with more than CAD21 million of commitments, without an exact corpus. Its current eight-person directory includes two advisers; former 2021 titles are not asserted current. The founder’s current biography says formed in2019, while the 2021 announcement says founded and seeded in February2020; founded is left NULL rather than silently resolving that discrepancy. Carebook’s own filed circular identifies an affiliated shareholder as Esplanade HealthTech Ventures I, G.P.; that does not establish the registered management-company suffix or a new manager identity. Exact management-company registration, underlying Override subscriber, and Fund II’s final corpus and closing date remain unverified. No third-party-only legal Inc. suffix, residual amount, fund target or internal AI-fund filter is treated as verified legal fund cash.

Alexandre Nossovskoi is an Esplanade principal investing in digital health and AI. Previously a Sixty Degree Capital principal, he also helped develop Creative Destruction Lab’s health programme and worked at iGan Partners. He earned an innovation and entrepreneurship master’s degree at Queen’s.

Ella Seitz is Esplanade’s managing partner. Previously a McKesson vice president, she led healthcare strategy, transactions, innovation and business development; earlier she was a Kearney principal. She earned an Ivey MBA and McGill commerce degree. Current heading and founder announcement substantiate her promotion beyond the bio’s generic partner wording.

Josh Blair is Esplanade’s venture partner, supporting digital-health investments, commercial strategy and business development. His current biography describes healthcare-technology operating and investment experience. The firm’s 2021 announcement described a general-partner role; that historical title is not substituted for the current venture-partner title.

Kavuchaljan Ganesathasan is Esplanade’s vice president of finance. Previously a Novartis financial-reporting manager, he advised on complex accounting, product launches and divestments. Earlier he audited public and private companies at KPMG. He studied commerce and professional accountancy at Concordia.

Sheldon Elman is Esplanade’s co-founder and chairman, a Montreal family physician and Medisys Health Group founder. He chaired Medisys until its 2018 sale to TELUS Health and co-founded Persistence Capital Partners. He studied medicine at McGill and maintains a medical practice.

Simon Kennedy, the Canadian former deputy minister, is Esplanade’s senior advisor. He led Innovation, Science and Economic Development from 2019 to 2024 and Health Canada from 2015 to 2019. His education includes INSEAD, Syracuse and Mount Saint Vincent. He is distinct from the Neo-Bionica electronics engineer with the same name.

Stuart M. Elman co-founded Esplanade and Persistence Capital Partners. Previously Medisys CFO and president, he led its 2002 IPO and 2008 going-private transaction. Earlier he worked in strategy and acquisitions at Trader Classified Media. He studied at Western’s Ivey business school.

Yosef Berlyand is an Esplanade advisor and Brown-affiliated academic emergency physician with expertise in care operations, quality and patient safety. He studied medicine at Harvard and completed emergency-medicine training at Massachusetts General and Brigham and Women’s hospitals. He researches care redesign and digital health.

Alynda (Lyndie) Wood is publicly identified as acting chief of staff in NINDS’s Office of the Director. The institute’s staff and director-office material identify the role and acting designation. Her primary Emory graduate-school account describes prior neuroscience research on skill learning and participation in a science-policy advocacy workshop. The acting agency office is kept distinct from a research-grant principal investigator or personal institutional-investment check.

Annette Gilchrist oversees NINDS SBIR/STTR drug-development projects, with the staff page calling her a programme officer and the programme-contact page calling her programme director for drug development. She joined NINDS in2022 after Midwestern University teaching and drug-discovery work. Her research background includes GPCR screening and co-founding MyGenomeRx, Cue Biotech and Caden Biosciences. Her PhD is in immunology from Connecticut. The own staff page uses a generic placeholder, which is excluded as a portrait.

Jessica Forbes is NINDS’s publicly listed scientific programme manager for its small-business programme. The official current programme contact roster establishes this specific NIH neuroscience-funding affiliation. It is distinct from similarly named physicians, interior designers and musicians. No broader employment history, exact appointment day, authentic photograph or personal investment is asserted where the primary source does not publish it.

Taryn Aubrecht is the named NINDS small-business programme contact for clinical and research tools. The current official programme page identifies this precise scope, while older2022 materials used a health-programme-specialist title. The newer published programme-director wording is retained with source qualification. This administrative and scientific role supports neurological technology research; it does not identify a personal investor or imply cash paid to any particular recipient.

Joe Kraus is a technology entrepreneur and investor whom Lime’s own October2019 publication identifies as its President after moving from a partner position at Google Ventures. Lime again quoted him as President in November2023. These are dated historical affiliations; the current English leadership directory does not establish that he still holds that title. Synapticure names Joe Kraus personally, qualified by Lime, among investors in its seed round closed in earlyfall2021 and announced February2022. No Lime or GV corporate investment follows from that identity wording. Name-bound original publisher portraits were identified but their public asset hosts returned403; no uncertain headshot was substituted.

Emily Caporello is listed as director of the NINDS small-business programme on its published programme-contact page. More recent first-person departure evidence reproduced in a public professional post says she moved to FDA’s Office of Neurological and Physical Medicine Devices as deputy director after leading the NINDS programme for seven years. Her NINDS affiliation is therefore explicitly historical/last-published; an exact departure day is not inferred from relative post dates. Programme leadership is not a personal company check.

David Hodgson is Vice Chairman of General Atlantic, whose current biography says he joined in1982 as its third investment professional and has worked across the firm’s investment sectors for more than40years. He holds a Dartmouth AB in mathematics and social sciences and an MBA from Stanford Graduate School of Business. Dartmouth’s2012 trustee announcement independently identifies David C. Hodgson as this same General Atlantic investor. Synapticure’s February2022 launch names David Hodgson personally among its seed investors; this personal participation does not establish a General Atlantic corporate check. An authentic current employer portrait was identified but its public host returned403, so no substitute picture is asserted.

John Ngai directs the NIH BRAIN Initiative and is listed in the NINDS leadership directory under its BRAIN office. NIH’s2020 appointment announcement and his former employer UC Berkeley identify the neuroscience researcher who moved from Berkeley to the cross-institute initiative. His work concerns neural circuits and cell types. The authentic Berkeley appointment portrait is used; the initiative is not represented as a separate company cash payer.

Clinton Wright is the physician-scientist leading NINDS clinical research, named as associate director for clinical research on its current leadership directory. His individually identified Bethesda neurology physician profile corroborates his NINDS division leadership and provides a genuine portrait. This is the NIH neurological-research leader, separate from similarly named lawyers, judges and photographers. The division role establishes institutional research administration, not a personal investment.

Amir Tamiz directs NINDS translational research. He previously oversaw Blueprint Neurotherapeutics and IGNITE programmes linking neuroscience discoveries to therapeutic development. Before joining NIH in2012 he held drug-development positions at Corvas International, CovX and Alba Therapeutics. His doctorate is from Oregon, followed by Georgetown neuroscience postdoctoral work. His authentic BIO convention speaker photograph documents the same scientist; the current NINDS directory determines the present title.

Avindra Nath is NINDS clinical director and an intramural senior investigator studying neurological consequences of infection and immune responses. His official NIH investigator profile identifies clinical and laboratory work concerning HIV and other infections of the nervous system. The same source supplies his genuine named portrait. Clinical research supervision is not evidence of a personal venture investment.

Patrick Bellgowan is NINDS’s acting associate director for neuroscience in the current official leadership directory. Official FITBIR speaker material describes a behavioural-neuroscience PhD from Wisconsin-Milwaukee and neuroimaging training, followed by cognitive-neuroscience work in Tulsa. He joined the NINDS extramural programme in2014 and managed traumatic-brain-injury research. His authentic2016 neurotrauma-conference portrait is retained as historical photography, without treating its older title as his current office.

Andrea Meredith joined NINDS in November2024 to direct its Division of Extramural Activities. She coordinates grant-related operations, training, research quality and data/analytics functions. Previously a physiology professor at the University of Maryland, she investigated BK potassium channels and KCNMA1 channelopathy, connecting ion-channel function with neurological disease. Her own current leadership and staff pages establish the exact scientist; an unrelated similarly named association officer is excluded.

Jeffrey S. Diamond leads NINDS intramural science. The official NIH Intramural Research Program profile confirms his permanent appointment as scientific director in August2023 following an acting period. His laboratory studies synaptic physiology, including how neurons communicate and how synaptic processes shape neural computation. The primary NIH publisher supplies the genuine named portrait; director and research roles do not establish personal equity investments.

Jill R. Harper is named on NINDS’s current leadership directory as acting deputy director for scientific management and operations and acting executive officer. She oversees institute scientific-management and operational support through OSMO and the Office of Management. Her NINDS agency duties are distinct from a venture-investment role; no personal company check is inferred. A genuine individually attributed portrait could not be recovered from the blocked publisher site.

The National Institute of Neurological Disorders and Stroke (NINDS) is the United States NIH component supporting research on the brain, nervous system and neurological disease. Congress created its predecessor in1950 as the National Institute of Neurological Diseases and Blindness; the current name dates to1988. The exact ninds.nih.gov public institution is represented separately from its NIH parent, other NIH institutes, private foundations and individual researchers. The authentic NIH institutional mark is shared parent branding, expressly qualified here; it is not presented as a separate NINDS-specific seal. Its activities encompass basic neuroscience, intramural laboratory and clinical research, extramural grants, neural technology, translational drug/device development and neurological clinical research. Relevant programmes include SBIR/STTR, Blueprint Neurotherapeutics, IGNITE and the cross-NIH BRAIN Initiative. Programme allocations and Congressional appropriations are agency budgets, not LP fund raises; awards are not equity investments or proof of recipient bank disbursement. No private venture funds or corporate cash raises are invented. The public profile captures all nine currently named institute leaders, the acting chief of staff and four publicly listed small-business programme contacts: fourteen individually sourced people and fourteen scoped roles. Acting titles are retained. Amy Bany Adams is the current acting director, with an official January2026 transition source; the existing AmyAdams NIH person and outside NIH role are preserved. Emily Caporello is explicitly last-published/former because newer first-person evidence reports her move to FDA, despite the older programme-contact page still naming her. Seven genuine individually attributed portraits were recovered from NINDS, NIH intramural research, a former employer and original professional speaker/physician publishers. Seven others remain explicit source/access gaps; generic placeholders are excluded. The wider451-entry staff directory and external advisory council are not asserted as a complete employee census or current appointments where terms/access cannot be verified. The investment relationship graph can represent exact administered research-award notices, separately from equity. NIH RePORTER identifies five distinct annual NINDS-administered Synapticure awards under NS124457, NS134458 and NS143521, with exact recipient legal identity and notice dates. Published annual award amounts are obligations/awards, not additional cumulative headline cash or confirmed paid bank cash. The sole Synapticure issuer owner maintains those five relationships; no duplicate NIH-parent allocation or personal leader check is inferred.

Jimmy Comfort is the venture partner in Meridian Street Capital’s current official team directory. His affiliation is within the firm’s specialized early-stage healthcare and technology investing platform. The own website publishes a genuine individually associated portrait and exact title; no unsupported operating-company career, personal cash check or precise appointment date is inferred.

Caroline Targgart is the executive assistant listed in Meridian Street Capital’s current public team. This is an administrative affiliation within the healthcare investment firm, rather than an investment-partner or portfolio-company executive role. The official directory supplies her genuine named photograph; earlier employment and an exact appointment day remain unpublished.

Matt Shiflett is director of finance at Meridian Street Capital according to its current public directory, a finance function distinct from a general-partner investment role. His own manager-linked professional profile identifies CPA in its URL. The official named portrait is authentic; prior career, qualification date and joining day are not established by the directory.

Brianna Yarnoff is an investor in the complete current public Meridian Street Capital team directory. She works within the firm’s early-stage healthcare and technology investment platform. The own directory publishes her genuine individually associated headshot and exact title Investor; no unsupported principal rank, appointment day, education or earlier employer is inferred.

Robel Mulugeta is an investor listed in Meridian Street Capital’s current public team. The firm specializes in early-stage technology and healthcare businesses, including clinical AI, care delivery and health-data infrastructure. His exact directory rank is Investor; the manager publishes a genuine named photograph but no full public career chronology or exact appointment day.

Chen Zhao is published on Isaac Health’s About page as a medical director and behavioral neurologist, alongside an authentic named clinical portrait. She is absent from the main current care-team directory, and the linked individual biography currently returns404. The affiliation is therefore scoped to the published About listing, with present employment/status unverified; no personal cash or legalcompanydirectorship is inferred.

Ahmed Yahia Al Idrissi is published by MGX as Managing Director; Chief Executive Officer; Investment Committee Chairman; Group Board Member; Board Executive Committee Member. Previously CEO of Private Equity at Mubadala and a McKinsey partner leading principal-investor and Abu Dhabi practices. Holds MIT and École Centrale Paris engineering degrees.

Ali Osman is published by MGX as Chief Investment Officer, Artificial Intelligence; Investment Committee Member. Previously spent over fifteen years at Mubadala, established its direct-investment technology unit and co-founded its life-sciences unit. Holds a Harvard MBA and a Tufts mechanical-engineering degree.

Amal Al Qasim is published by MGX as Chief of Staff to the CEO; Management Committee Member. Previously ran direct-investment CEO-office operations at Mubadala, including coordination across offices and portfolio relationships. At MGX coordinates CEO priorities and governance matters; holds a business-administration degree from the Higher Colleges of Technology Dubai.

Andre Namphy is published by MGX as Chief Legal Officer; Investment Committee Member; Management Committee Member; Board Secretary. Previously general counsel for Mubadala’s direct investments and corporate finance and treasury functions. Earlier practised at Sullivan & Cromwell; studied at Harvard, Oxford and Yale Law School.

Danny Dweik is published by MGX as Chief Operating Officer; Chief Finance Officer; Investment Committee Member; Management Committee Co-Chair. Previously led industrials, business services, energy and sustainability investments at Mubadala. Earlier served in executive roles at Nova Chemicals and Emirates Global Aluminium and as an associate partner at McKinsey.

David Scott is published by MGX as Chief Strategy and External Affairs Officer; Investment Committee Member. Strategy executive whose MGX biography also describes oversight of AI safety criteria and portfolio risk. Previously led economic and energy affairs at Abu Dhabi’s Executive Affairs Authority, worked at Occidental Petroleum and served in US foreign-policy roles. Distinct from the same-name Arbor Biotechnologies co-founder.

Guy Harmelin is published by MGX as Chief Investment Officer, Advanced Technology; Investment Committee Member. Physician and technology investor, previously an adviser to G42 and CIM Group and an investment executive at 7-main and Harel. Co-founded computational drug-discovery company RondinX and Ayala Pharma; holds an MD from the University of Florence.

Jassem Al Zaabi is published by MGX as Group Board Member; Audit and Risk Committee Chairman; Board Executive Committee Member. MGX identifies his full name as Jassem Mohammed Bu Ataba Al Zaabi and publishes him as chairman of Abu Dhabi’s Department of Finance. His group-board duties include chairing the audit and risk committee.

Laila Saif is published by MGX as Chief People Officer; Management Committee Member. Human-capital executive, previously director of human capital at Emirates Global Aluminium and head of human-capital business partners at Mubadala. Earlier worked at GE Capital and holds an EMBA from the Higher Colleges of Technology in Abu Dhabi.

Martin Edelman is published by MGX as Group Board Member; Nomination and Remuneration Committee Member. Lawyer with international transaction experience, general counsel of G42 and adviser to Mubadala and Redbird IMI. MGX publishes him on its group board and nomination and remuneration committee.

Misha Logvinov is published by MGX as Chief Technology Officer; Management Committee Member; New York Office Lead. Previously a senior operating partner at Mubadala and managing director and head of technology strategy at EQT. Earlier held executive roles at Oracle and Lithium Technologies; leads AI value creation across MGX investments and operations.

Omar Alismail is published by MGX as Chief Investment Officer, Semiconductors and Infrastructure; Investment Committee Member; Management Committee Member. Previously established Mubadala’s operating-partners team and served as deputy CFO of GlobalFoundries, helping lead its 2021 IPO. Holds finance and business degrees from Imperial College London and the American University of Sharjah.

Peng Xiao is published by MGX as Group Board Member; Board Executive Committee Chairman; Nomination and Remuneration Committee Chairman; Audit and Risk Committee Member. Group CEO of G42, overseeing its AI and technology businesses. Previously senior executive vice president, chief technology officer and chief information officer at MicroStrategy.

Tahnoon bin Zayed Al Nahyan is published by MGX as Chairman (MGX Group Board). Deputy Ruler of Abu Dhabi and UAE National Security Advisor. Chairs Abu Dhabi’s Artificial Intelligence and Advanced Technology Council; MGX publishes him as chairman of its group board.

Scott Law is a partner in Meridian Street Capital’s current directory, investing in early-stage healthcare and technology businesses. The March12,2026 statutory adviser filing identifies Thomas Scott Law as general partner and its signatory as T.ScottLawJr, managing partner; the manager’s2022 and2026 fund notices use Thomas Scott Law Jr., managing member of the funds’ general partner. His identity is kept distinct from senior-generation or similarly named Zotec executives; no unsupported prior operating career is imported.

Todd J. Miller is a Confluent Health board member. The published corporate biography identifies Partners Group private-equity Americas leadership, prior Sterling Partners and Tri-Artisan Capital roles, and earlier Merrill Lynch credit-capital-markets work. He holds a University of Michigan economics bachelor’s degree. Current corporate board membership is sourced to Confluent’s live roster; older Partners Group title details are retained as source-published career history rather than independently assumed current manager appointments.

David Jones Jr. is a Confluent Health board member and founder/managing director of Chrysalis Ventures. His own corporate biography describes healthcare and education investing, Humana board service since1993 and chairmanship during2005–2010, prior legal work including the US Department of State, and earlier Bank of Boston experience. His education includes Yale and legal training. The board appointment does not imply a personal cash allocation; Chrysalis was separately named an institutional minority investor. His current Chrysalis biography identifies him as Chairman and Managing Partner of the firm he founded in1993 and says his Humana board service ended in April2023. His current education is Yale BA and JD. Existing Confluent biography and authentic portrait are preserved.

Jody Bilney is named on Confluent Health’s current board. Her biography describes consumer, marketing and digital leadership as Humana’s chief consumer officer from2013 and earlier brand leadership at Bloomin’ Brands, Charles Schwab and Verizon. She holds a Clemson economics bachelor’s degree with a marketing minor. The biography’s older outside appointments are historical/source-published career information rather than newly verified current roles.

Piotr Biezychudek is a Confluent Health board member and a Partners Group Private Equity Health and Life professional based in Denver. His published biography names earlier roles at KRG/Mountaingate, Edgewater,3i and JPMorgan Securities. He holds a Chicago Booth MBA and a finance bachelor’s degree from the University of Illinois Urbana-Champaign. The board role establishes institutional affiliation, not a personal investment.

Jim Greenwood is named board chair of Confluent Health in the current corporate roster. His healthcare-services career includes approximately20years at Concentra, subsequent Humana work, CEO leadership of Vision Source from2013 and executive-chair involvement in Retina Consultants of America from2019. These historical operating and investment roles identify the healthcare executive, not another similarly named politician or biotechnology trade-association leader.

Mark Steiger is Chief Operating Officer at Confluent Health, covering shared services, outpatient partner brands and virtual-care operations. He previously led Optum behavioral and urgent-care operations and held digital-health and clinical-operations leadership at Optum and Ascension. His own biography identifies an MBA from UT Austin’s McCombs School and a UT health-informatics faculty affiliation; no exact appointment day is inferred.

Jason Somrock is Confluent Health’s Chief Payer & Network Development Officer, responsible for payer contracting, reimbursement strategy, network expansion and value-based care. The own appointment announcement describes more than20years of healthcare leadership, including nearly two decades in UnitedHealth Group corporate development and provider relationships across UnitedHealthcare and OptumRx. His prior chief-commercial role at technology-enabled healthcare businesses is historical.

John Lacy is Chief People Officer at Confluent Health. His HR leadership history includes Methodist Health System, Baptist Memorial, Baylor Scott & White and Walmart healthcare, followed by chief HR leadership at AmeriVet Veterinarian Partners. His current remit includes recruitment, engagement, workforce development and people systems across the group.

Tony Kaczkowski is CEO of Confluent Health’s Industrial Health & Safety Solutions division, including Fit For Work, WorkSTEPS and IAA. His clinical and executive career spans occupational and musculoskeletal health, injury prevention, ergonomics and employer-based services. He founded and expanded InSite Health before its merger into Briotix Health. The parent’s October6,2026 announcement confirms this newly appointed division role; it is not parent-company CEO.

Scott Farnsworth is Confluent Health’s Chief Information Officer, responsible for IT and project-management functions. He began his clinical career as an ICU nurse and has held technology leadership positions at Visor Health, CareAbout Health, Humana and Kindred Healthcare. His own profile combines clinical-care experience with engineering and healthcare-technology work.

David Eby leads Evidence In Motion, the education business represented in Confluent Health’s executive directory. His higher-education career includes serving as COO of Project Kitty Hawk in partnership with the University of North Carolina and CMO at Southern New Hampshire University. The own biography also describes work with Thinkful, HotChalk and Education Sales Management. This is explicitly an operating-business leadership affiliation, not CEO of the Confluent parent.

Meg Dietzel is Confluent Health’s Chief Marketing Officer. Her own biography describes earlier senior leadership at Patterson Dental and service as a US Air Force meteorologist. She helped develop Patterson’s Women in Dentistry programme and now manages the group’s marketing, brand and healthcare-partnership work. Previous roles are historical.

Stephen Clark, PT, DPT, OCS, ATC, is Confluent Health’s first Chief Clinical Officer. He joined Texas Physical Therapy Specialists/Confluent in2014, attained orthopedic board certification in2015 and previously directed clinical innovation. His own biography describes clinical operations work with Walmart Health and a2022 transition to moviHealth. His current clinical leadership works alongside COO Mark Steiger to support outpatient partner brands.

Jeremy Burtel is publicly named Chief Financial Officer of Confluent Health in the current executive directory, with an original caption-bound portrait. His individual biography currently says coming soon; education, previous employers and exact appointment date remain unverified.

Confluent Health is a privately held US musculoskeletal healthcare group operating physical and occupational therapy, chronic-pain care, injury-prevention services and clinician education. Its current website describes more than60 partner brands and over1,650 sites of care. The company supports independent clinical practices with shared operations, payer networks, value-based care programmes and education through Evidence In Motion. Industrial Health & Safety Solutions comprises workplace-health businesses including Fit For Work, WorkSTEPS and IAA. The legal corporate sponsor is Confluent Health LLC, headquartered in Louisville, Kentucky. This is separate from Confluent enterprise data-streaming software and similarly named financial or hospital organizations. The group also undertakes strategic investment and digital-care development. Confluent Health Innovations LLC was introduced in2022 as a dedicated internal portfolio of venture investments, value-based programmes and emerging services, under then strategy leader Brooks Newman. The programme is not represented as an independent closed LP fund. Override Health’s actual2022seed names the Confluent parent as a participant; underlying subscribing affiliate and allocation are undisclosed. A separate December13,2022 BehaVR/OxfordVR issuer release explicitly names Confluent Health as a participant in an initial USD13million SeriesB; this is independent investment evidence, with its allocation and subscribing affiliate unknown. Curable and Walmart collaborations remain partnerships without verified investment cash. Historical capital events include Edgewater investments in2016 and2017 and the2019 equity acquisition/investment by Partners Group on behalf of clients, with Edgewater exiting. Chrysalis Ventures was later announced as a minority investor. Values and exact completed cash dates are not disclosed in these sources, and ownership transactions are not converted into new corporate financing amounts. The own current executive and board directories are maintained as source-qualified corporate affiliations, with division heads distinguished from parent executives. The group’s relevance to neuroscience is chronic pain and rehabilitation; no neural implant, drug-development or AI-specialist claim is invented.

Kristi Henderson, DNP, leads Confluent Health as CEO and appears on its published board roster. Her career includes leading Optum Everycare, Amazon Care clinical operations and Ascension virtual-care and patient-access services. Her clinical background is nursing and advanced practice; the own biography also identifies telemedicine leadership and academic affiliations at UT Austin and the University of Washington. Prior positions are historical, not additional current employment claims.

NBCL (Novel Biomarkers Catalyst Lab) develops and manufactures point-of-care immunoassays and diagnostic instruments in Nijmegen, the Netherlands. Its CONNECT analyzer measures intact parathyroid hormone from a whole-blood sample in about five minutes, bringing biochemical information into the operating room during parathyroid surgery. Disposable cartridges, barcode scanning, calibration and quality controls support testing without routine sample preparation or a central laboratory workflow. The company also develops immunoassays and provides assay-development and production expertise. CONNECT is used in hospitals across Europe and other EMEA markets. Its US market entry remains under development, and NBCL states that its intraoperative PTH test is not FDA-cleared or approved for US sale. A separate EFRO-supported EAGLE-EYE application for rapid assessment of parathyroid function is still undergoing technological development and clinical validation.

Angela Marte Villa is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Angelica Peguero is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Bianca Nazal is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Chris Rosmalen’s public professional profile identifies an NBCL affiliation and shares its intraoperative-diagnostics and conference activities. His exact current position is not visible in the primary profile. An older secondary CEO listing is not used to override the company’s current CEO, Herbert Torfs.

Dominique Clarysse is named by NBCL as a colleague and conference representative discussing intraoperative PTH testing with clinicians. The company publishes participation in its French endocrine-surgery meeting and US market-development activities without a specific rank.

Dulce Vazquez is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Edmond Insinger is named in NBCL’s company post as participating with Herbert Torfs in the Texas Medical Center BioBridge visit, meeting clinicians, hospital leaders and innovators. The source establishes this representative activity, not an employee position, legal directorship or personal investment.

Erica Hodgdon is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Gisela Vargas is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Herbert Torfs is NBCL’s CEO and is also identified as Commercial Director in its December2025 investment announcement. He represents the company’s intraoperative diagnostics business at endocrine-surgery conferences and in its US market-development programme. The issuer’s2024 welcome describes experience in the diagnostics industry.

Hossein Estiri is an Isaac Health advisory-board member focused on clinical artificial intelligence. Harvard identifies him as an associate professor of medicine and the leader of Massachusetts General Hospital’s Clinical Augmented Intelligence group. His research combines informatics, computational social science and healthcare data.

Joshua Wilson is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Marvin Mauricio is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Matt Thomason was introduced by NBCL as its UK and Ireland National Sales Manager in November2023. Company-reposted customer activity continues to associate him with CONNECT adoption in British hospitals, while his current exact title and legal employment arrangement remain unverified.

Micah Tart is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Rob Lips is named by NBCL as a colleague and company representative at clinical conferences and US market-development visits. His public profile describes international general-management experience; the issuer does not publish a specific current management rank in the reviewed sources.

Robert van Vliet is NBCL’s Head of Global Marketing and Field Applications. The company names him as a representative at its May2026 ESES Geneva booth, discussing the CONNECT analyzer and intraoperative PTH workflows.

Steven van Lierop was welcomed by NBCL as technical director in November2023. The issuer cites his experience in in-vitro diagnostic operations and technology. Current tenure and a precise employment end date are not established by the reviewed company sources.

Tabitha Hancock is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Thalia Montes is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Ashley Bryant is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Briana Edwards is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Danica Danelle Escalona is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Derek Flanzraich is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Gary Jessee is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Jalquala Evans is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Jennie Shulkin, also legally Jennifer Shulkin in SEC filings and issuer press contacts, co-founded Override with her father DavidShulkin after personal chronic-pain experience. She served as founding CEO; the own July10,2024 announcement says she transitioned to president when KiliPreitauer became CEO. The current own site describes her as founder, while its currentboard roster omits her, so the2024president/board offices are scoped historically and are not asserted ascurrent. An authentic portrait was not retrieved.

Jessica Bernardino is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Jessica Muse is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Jhenifer Estevez is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

LaTeka Hampton is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Lainey Castiglione is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Meghan Bomba is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Monica Johnson is listed in Isaac Health’s public care-team directory as Care Navigator. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Peter Yan is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Ross Hoffman is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Sean Zhao is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Chris Bowers is listed in Isaac Health’s public care-team directory as Advisor. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Erica Allen is listed in Isaac Health’s public care-team directory as Director of Care Navigation. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Keji Adetola is listed in Isaac Health’s public care-team directory as Director of Client Success. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Latisha Chaney is listed in Isaac Health’s public care-team directory as HR Generalist. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Lauren Pollitt is listed in Isaac Health’s public care-team directory as Director of Revenue Cycle Management. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Michael Choe is listed in Isaac Health’s public care-team directory as Director of Finance. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Bryn Loeffler is listed in Isaac Health’s public care-team directory as VP of Business Operations. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Karlan Eberhardt is listed in Isaac Health’s public care-team directory as VP of Technology. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Alison Boyle is listed in Isaac Health’s public care-team directory as Lead Speech Language Pathologist. The issuer biography describes Alison Boyle is an experienced Speech-Language Pathologist with a robust background in medical speech-language pathology, clinical leadership, and community engagement. She is experienced in cognitive-communication rehabilitation and brain health, providing evidence-based interventions to support memory, attention, executive function, and language in older adults. Boyle has a proven track record of developing and managing comprehensive clinical education programs, fostering strong community partnerships, and enhancing patient, caregiver, student, and faculty growth. She is a compassionate clinician and dedicated advocate devoted to making a meaningful difference each day through innovative, person-centered care, interdisciplinary collaboration, and lifelong learning. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Anamaria Freeman is listed in Isaac Health’s public care-team directory as Neurology Nurse Practitioner. The issuer biography describes Anamaria Freeman, ACNP-BC is board-certified Acute Care Nurse Practitioner with a focus on neurology. With over 9 years of direct patient care experience, she is passionate about providing high quality care for patients and bridging access to care via telehealth. She completed her neurology training and preceptorship at Cedars-Sinai Medical Center. Freeman has worked in Cardiothoracic Intensive Care Units and Neurology. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Dr. Catherine Russell is a licensed physical therapist with over 15 years of experience in outpatient, inpatient, and home health care. At Override, she helps patients with chronic pain regain movement and confidence through evidence-based therapy, pacing, and education. Drawing on her background in digital health and rehabilitation, she integrates physical and behavioral strategies to support lasting recovery.

Fhteachia Andrews is listed in Isaac Health’s public care-team directory as Psychiatric Nurse Practitioner and Neurology Nurse Practitioner. The issuer biography describes Dr. Fhteachia Andrews is a dual-licensed and dual-board certified Family Nurse Practitioner and Psychiatric Mental Health Nurse Practitioner, who also obtained her Doctor of Nursing Practice degree. She received her first Bachelor’s Degree in Biology in 1994 and furthered her education by obtaining her Master’s of Biomedical Sciences degree. In addition, she obtained her second Bachelor’s of Nursing degree in 2011, her Master’s of Nursing degree with the Family Nurse Practitioner track and Doctor of Nursing Practice degree from Union University in Jackson, TN. Dr. Andrews attended Florida Atlantic University where she obtained her Post-master’s Psychiatric Mental Health Nurse Practitioner Certification. As a nurse, she worked as a RN Unit Manager at a Skilled Rehabilitation Center/Nursing Home. As a nurse practitioner, Dr. Andrews has worked in a variety of settings, which include inpatient hospitalist role and cardiology role, neurology both inpatient and outpatient settings, transition of care, hospice, endocrinology, both inpatient and outpatient psychiatry. Dr. Andrews provides empathetic, holistic, and culturally competent care by being authentic in her approach. She is truly interested in helping individuals strive towards and reach their own personal optimal well-being. She lives in Florida, with her husband, mother, 2 sons, a daughter-in-love, and a Havanese dog named “Miracle”. For fun, she loves watching movies with her family, spending personal time with her family including two grandchildren, cruising, vacationing, and focusing on staying healthy. She loves to encourage others to be the best they can be in their lives holistically. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Halie Holden is listed in Isaac Health’s public care-team directory as Neurology Nurse Practitioner. The issuer biography describes Halie Holden, MSN, FNP-BC is a neurology nurse practitioner at Isaac Health. She is certified by the American Association of Nurse Practitioners and received her Master of Science in Nursing from Azusa Pacific University. Why I joined Isaac Health My specialty in Neurology has always been dementia care because it is very personal to me. There is a strong genetic predisposition in my family and I watched both my great grandmother and grandmother decline from dementia, until they ultimately passed away. This experience shaped my passion for dementia care and continues to motivate me to make a meaningful difference in the lives of patients and their families. Because of this, I am deeply committed to ensuring that patients and their families feel supported, understood, and never alone throughout their journey. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Hunter Sinclair is listed in Isaac Health’s public care-team directory as SVP of Growth. The issuer biography describes or call us at (888) 818-2059 Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Julius Bruch is listed in Isaac Health’s public care-team directory as CEO and Co-Founder. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Kathryn Lesane is listed in Isaac Health’s public care-team directory as Lead Psychotherapist. The issuer biography describes Kathryn Lesane, LCSW is an accomplished licensed clinical social worker with more than a decade of experience in behavioral health therapy, clinical case management, and healthcare leadership. Her clinical work focuses on behavioral health and emotional wellbeing, providing therapy for individuals and families coping with anxiety, depression, grief, chronic illness, and cognitive decline. Her therapeutic style is trauma-informed and strengths-based, combining supportive counseling, cognitive-behavioral interventions, and solution-focused techniques to help clients build resilience and achieve meaningful change. She is deeply committed to helping patients and caregivers navigate emotional transitions with understanding and empowerment. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Katlyn Salvatore is listed in Isaac Health’s public care-team directory as Neurology Nurse Practitioner. The issuer biography describes Katlyn Salvatore is a board-certified Family Nurse Practitioner who has dedicated her career to neurology. Katlyn provides expert, compassionate care to patients and their families while navigating cognitive concerns. Katlyn Salvatore is a board-certified Family Nurse Practitioner who has dedicated her career to neurology. Katlyn provides expert, compassionate care to patients and their families while navigating cognitive concerns. Her mission is rooted in a simple but powerful philosophy: providing high-quality neurological support that prioritizes the dignity, comfort, and unique needs of every individual, regardless of their geographic location. Katlyn’s journey into healthcare began in the high-stakes environment of the Neurological Intensive Care Unit. Starting as a technician during her college years, she developed a foundational understanding of the complexities of the human brain and the resilience of the human spirit. After transitioning into a role as a Registered Nurse within the same ICU, Katlyn witnessed firsthand the critical intersections of acute neurological trauma and long-term recovery. These formative years instilled in her a profound sense of empathy and a drive to provide better long-term outcomes for patients facing life-altering diagnoses. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Kristie Figueroa is listed in Isaac Health’s public care-team directory as Speech Language Pathologist. The issuer biography describes Kristie Figueroa is a Speech Language Pathologist with over 15 years of experience. Kristie is a Speech Language Pathologist and Certified Brain Injury Specialist with over 15 years of experience evaluating and treating cognitive communication impairments in inpatient, outpatient, skilled nursing and assisted living facilities. During her time with Isaac Health, she has provided skilled assessment and intervention helping patients diagnosed with MCI, dementia, and other neurological conditions through evidence-based strategy training, cognitive exercises, and home program development. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Laurie Weinberg is a licensed clinical social worker with over 20 years of experience in adult mental health, addiction, and life transitions. She practices a collaborative, evidence-based approach grounded in mindfulness, ACT, CBT, DBT, and person-centered therapy. At Override, she helps patients with chronic pain build resilience, reframe unhelpful thought patterns, and develop coping strategies that improve daily function and well-being.

Madeline Lepre is listed in Isaac Health’s public care-team directory as Speech Language Pathologist. The issuer biography describes Madeline is an ASHA-Certified Speech-Language Pathologist specializing in the treatment of adults with cognitive-communication disorders related to stroke, traumatic brain injury, neurological conditions, and progressive diseases. With clinical experience across hospital, rehabilitation, and outpatient settings, Maddie delivers specialized, evidence-based cognitive-communication rehabilitation focused on promoting brain health and maintaining functional independence. At Isaac Health, she works with adults navigating mild cognitive impairment (MCI), dementia, and other neurodegenerative conditions, providing skilled care across every stage of cognitive change. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Natalie Farnsworth is listed in Isaac Health’s public care-team directory as Neurology Nurse Practitioner. The issuer biography describes Natalie Farnsworth, MSN, FNP-BC, is a highly dedicated and board-certified Family Nurse Practitioner with a profound commitment to patient-centered care and over a decade of comprehensive nursing experience. Since earning board certification in 2020 through the American Nurses Credentialing Center (ANCC), Natalie Farnsworth has leveraged a strong clinical background to provide advanced, holistic care to diverse patient populations. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Navandeep Malhi is listed in Isaac Health’s public care-team directory as Neurology Nurse Practitioner. The issuer biography describes Navandeep Malhi, MSN, APRN, FNP-C is a board-certified Family Nurse Practitioner with over 10 years of clinical experience, including advanced practice in neurology. She is experienced in diagnosing and managing neurological conditions such as migraine, multiple sclerosis, dementia, Parkinson’s disease, and neuropathy. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Peter Muller is listed in Isaac Health’s public care-team directory as VP of Clinical Operations. This is the exact published affiliation; an investment, corporate directorship or other employer role is not inferred. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Shelley Johnson is listed in Isaac Health’s public care-team directory as Psychiatric Mental Health Nurse Practitioner. The issuer biography describes Shelley Johnson, FNP-BC, PMHNP-BC is a board certified Family Nurse Practitioner with over 16 years of experience with an additional certification in Psychiatric Mental Health Nurse practitioner. She is deeply committed to improving access to high quality care while supporting individuals and families through every stage of life. Shelley began her healthcare career as a registered nurse at he age of 23, an experience that created a strong foundation for her work as a nurse practitioner. Her early years as a nurse reinforced the importance of listening, and understanding how an illness can affect the whole person as well as their families. With 16 years of experience in primary care, Shelley has cared for patients across the lifespan and managed complex and chronic medical conditions with evidence-based medication. Her additional training in behavioral health strengthens a holistic approach to comprehensive dementia care. She integrates medical management with attention to mental health, behavior, functional ability, care-giver well-being and environmental factors. Her care approach emphasizes early recognition, clear communication, and practical guidance. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Vickie Thomas is listed in Isaac Health’s public care-team directory as Psychiatric Mental Health Nurse Practitioner. The issuer biography describes Vickie Thomas is a Psychiatric Nurse Practitioner. She is originally from Kentucky and obtained her Master of Science in Nursing through the University of Kentucky as a Psychiatric Mental Health Nurse Practitioner (PMHNP). Thomas is credentialed to provide psychiatric services across the lifespan and has experience working in multiple outpatient clinics and inpatient hospitals. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Whitney Dee-Lapointe is listed in Isaac Health’s public care-team directory as Speech Language Pathologist. The issuer biography describes Whitney Dee-Lapointe is an accomplished and compassionate Speech-Language Pathologist (SLP) dedicated to maximizing the communication, cognitive, and swallowing function of adult patients. With a Master of Arts in Speech-Language Pathology from the University of Maine at Orono, she brings extensive experience in complex healthcare settings, focusing on creating personalized, evidence-based treatment plans that support patient independence and improve overall quality of life. Her clinical focus lies in the evaluation and treatment of adults facing challenges such as aphasia, dysarthria, cognitive-communication deficits, dysphagia (swallowing), and voice disorders. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Dr. Elisha Peterson is a triple-board-certified anesthesiologist and pain medicine physician who directs pediatric chronic pain programs and teaches integrated, biopsychosocial care. She trained in pain medicine at Harvard-affiliated programs, served as Director of Chronic Pain at a leading children’s hospital, and is an Associate Professor of Anesthesiology. Her approach emphasizes education, family engagement, and functional recovery for youth with complex pain.

Mithra Moon is a board-certified physician assistant specializing in pain management and musculoskeletal rehabilitation. At Override, she provides virtual medical evaluations and collaborates with the interdisciplinary team to develop targeted, evidence-based care plans for patients with chronic pain. Her experience spans orthopedic and spine care, telemedicine, and interventional pain management, with a focus on patient education, functional recovery, and whole-person care.

Dr. Carrie Johnson is a double board-certified anesthesiologist and pain medicine physician specializing in the treatment of complex and chronic pain. At Override, she provides comprehensive medical evaluation and guidance within an interdisciplinary care model, emphasizing functional recovery and patient education. Her practice combines evidence-based interventions, medication optimization, and behavioral integration to improve outcomes for patients with chronic pain.

Dr. Carnegie Truesdale is a licensed clinical psychologist with extensive experience in chronic pain management. At Override, she provides individual therapy for adults living with chronic pain, emphasizing education, self-regulation, and skill building. Her work includes supervising trainees and promoting interdisciplinary collaboration to improve patient care.

Dr. Sheryl Leytham is a clinical psychologist specializing in the intersection of chronic pain, trauma, and behavioral health. She has extensive experience in hospital and outpatient settings and has served as a pain specialist within interdisciplinary medical teams. At Override, she integrates CBT, ACT, and mindfulness to help patients reduce pain interference, improve sleep, and enhance emotional well-being.

Dr. Janna Gordon is a licensed clinical health psychologist who helps patients with chronic pain and medical conditions improve well-being and function through evidence-based psychological care. At Override, she uses cognitive behavioral therapy, acceptance and commitment therapy, and mind-body strategies to help patients build coping tools and align treatment with their values. Her collaborative, whole-person approach emphasizes resilience, self-efficacy, and sustainable recovery.

Founder and principal of Bridge Builders Collaborative, according to its own biography. Media executive, entrepreneur and investor with published interests in mind-fitness companies including Headspace, eMindful, Happify, Pear Therapeutics and Interaxon; also founded Chestnut Holding.

Entrepreneur and investor published among Bridge Builders Collaborative’s partners. Founded TOMS Shoes and its One for One business model; his published biography describes philanthropic interest in psychedelics.

Managing Director at Bridge Builders Collaborative. An entrepreneur and business leader with experience in corporate marketing, innovation consulting and expedition businesses; previously led Ideas to Go and founded yourexpedition. He holds a Harvard Business School MBA.

Jeffrey Walker, published as Jeff Walker by Bridge Builders Collaborative, is an investment partner focused on contemplation and mind training. Former CEO and co-founder of CCMP Capital and former JPMorgan Chase vice chairman; his published background also includes social-enterprise investing, New Profit and co-founding Npower.

Investor published among Bridge Builders Collaborative’s partners. Leads the Blake Family Foundation and Liz Blake Giving Fund, supporting early-childhood development, women’s financial empowerment and mental and behavioral health; formerly served as Habitat for Humanity International’s general counsel.

Operating Partner at Bridge Builders Collaborative and co-founder of ShiftIt Institute. A behavioral scientist with a background in psychotherapy, executive coaching and organizational consulting, she helped develop health-coaching curricula at the University of Minnesota.

Investor published among Bridge Builders Collaborative’s partners. Leads Mays Family Enterprises and Running M Capital; his published background includes senior leadership at Clear Channel and Live Nation and investment interests in neuroscience, consciousness and wellness.

Investor published among Bridge Builders Collaborative’s partners. Founded Ortus Foundation to support prevention and systemic responses to mental-health challenges among teens and young adults. Earlier worked in institutional investment marketing and raised capital for Valor Equity Partners.

Investor published among Bridge Builders Collaborative’s partners. His published biography describes leadership of Gloo and decades of experience developing businesses and platforms supporting relationships, spirituality and wellbeing.

Investor published among Bridge Builders Collaborative’s partners. Co-founded Juniper Networks and served as its CEO; co-founded the1440Foundation and1440Multiversity with Joanie Kriens to support relationships, learning and wellbeing.

Bridge Builders Collaborative is a private-investor collaborative backing technology companies focused on mental health, mindfulness, mind training and human wellbeing. Its published strategy typically targets Series A businesses with differentiated products, established product-market fit and clear distribution, and supports several follow-on rounds. Its portfolio spans EEG and neurofeedback devices, digital therapeutics, suicide-prevention services, pediatric behavioral healthcare, meditation platforms and technology supporting psychedelic therapy. Founded in2012, it brings together individual investment partners and operating support; a specific registered legal manager or recently closed pooled fund has not been verified.

Investment partner published by Bridge Builders Collaborative. Co-founded Canyon Echo Capital with Adam Lewis, investing in climate solutions, technology, human and mental health, and mindfulness; her background includes foundation work and leading Byron Katie’s organization.

Paul Curtis is a coach and exercise specialist who integrates strength, conditioning, and pain education to rebuild physical capacity. At Override, he designs gradual, goal-oriented movement plans to support recovery and confidence in activity.

Bobbie Seright is a health coach who applies mindfulness, pacing, and gratitude practices to help patients manage chronic pain. At Override, she teaches practical skills that enhance daily function and emotional resilience.

Kris Sutton is a pain coach certified in Pain Reprocessing Therapy (PRT) who uses neuroscience education and mindfulness to reduce pain anxiety and increase activity. At Override, she partners with patients to set achievable goals and track functional progress.

Kendy Anderson is a pain coach certified in Pain Reprocessing Therapy (PRT) who guides patients through pacing, activity planning, and cognitive reframing. At Override, she focuses on small, consistent progress that restores confidence and control over pain.

Karen Hsue is a health coach whose personal experience with pain informs practical, compassionate support. At Override, she helps patients build routines—movement, recovery, and stress management—that lower pain interference and enhance well-being.

Jaerene Robinson is a health coach and addiction counselor who addresses the overlap of chronic pain, stress, and substance risk. At Override, she teaches coping, craving management, and goal setting to support safer, sustainable pain recovery.

Brenda Craig is a pain coach certified in Pain Reprocessing Therapy (PRT) who leverages neuroscience, pacing, and mindset training to help patients replace reflexive pain behaviors with effective skills. At Override, she supports daily behavior change that reduces flare frequency and builds long-term resilience.

Dr. Erin Etzel is a clinical health psychologist who treats chronic pain, insomnia, and anxiety using cognitive behavioral and mindfulness-based therapies. At Override, she applies trauma-informed methods to improve regulation, sleep, and adherence to rehabilitation.

Dr. Dorota Novitskie is a psychologist trained in Pain Reprocessing Therapy who treats the psychological drivers of persistent pain. At Override, she guides patients to reinterpret pain signals, decrease fear, and resume activity.

Rachel Adler is a family nurse practitioner who manages chronic pain within primary and specialty care contexts. At Override, she collaborates across disciplines to optimize medications, sleep, and activity targets that support functional goals.

Dr. Iryna Wolberg is a nurse practitioner specializing in pain management, telehealth, and rehabilitation. At Override, she performs comprehensive medical evaluations and coordinates multimodal plans that align medical, behavioral, and physical therapy approaches.

Susan Hecht is a licensed clinical social worker with decades of experience integrating cognitive, behavioral, and holistic methods for chronic pain. At Override, she helps patients reduce catastrophizing, manage mood, and reengage in meaningful roles.

Rachel Cutts is a physical therapist who combines chronic pain management and performance principles to help patients—from active adults to athletes—return to meaningful activity. At Override, she pairs load management, nutrition-informed coaching, and pain education to accelerate functional progress.

Jill McCoy is a physical therapist specializing in chronic pain rehabilitation with a focus on measurable progress and functional restoration. At Override, she applies evidence-based rehabilitation, pacing, and patient education to support recovery after injury and surgery.

Trisha Tkach is a physical therapist with extensive experience treating complex chronic pain conditions, including TMD, lumbopelvic dysfunction, and shoulder disorders. At Override, she blends education, targeted exercise, and behavior change to reduce fear of movement and improve function.

Libby Darin is a physical therapist and Therapeutic Pain Specialist who helps patients with persistent pain restore mobility and confidence through education, graded exercise, and pacing. At Override, she builds simple, sustainable movement plans that reduce sensitivity and improve daily function.

Meghan Murphy is a physical therapist specializing in chronic pain, musculoskeletal dysfunction, and pelvic health. At Override, she integrates pain neuroscience education with progressive loading and self-management strategies to help patients reduce flare cycles and maintain long-term function.

Dr. Marissa Cohler is a board-certified Physical Medicine and Rehabilitation physician specializing in chronic pain and complex musculoskeletal conditions. At Override, she provides comprehensive evaluations and personalized medical strategies to optimize function and minimize pain through a multidisciplinary model. Her expertise in rehabilitation medicine and telehealth allows her to deliver coordinated, accessible care for patients living with persistent pain.

Monika Domke is a licensed clinical social worker who brings a mind-body approach to chronic pain management. At Override, she supports patients through therapies that combine cognitive behavioral and acceptance-based methods with mindfulness and somatic awareness. Her focus is helping individuals identify emotional and physiological triggers of pain and develop sustainable coping skills that improve overall well-being.

Dr. Lisa Ensfield is a licensed clinical psychologist specializing in chronic pain management. She helps patients navigate the emotional, behavioral, and cognitive impacts of persistent pain using evidence-based methods such as cognitive behavioral therapy, mindfulness, and acceptance-based approaches. Dr. Ensfield practices within an interdisciplinary model, collaborating with physicians, physical therapists, and pain coaches to improve patient outcomes and quality of life.

Christian Rische is published by Override as Board Observer & Investor. The company operates a virtual interdisciplinary chronic-pain care service spanning medicine, rehabilitation, health psychology and coaching. Further education and detailed career history are not exposed by the current own directory and are not inferred.

Reena Pande, MD, is published by Override as a board member and clinical adviser. AbleTo’s own2019–2020 releases identify her historical chief medical officer role and her work on access to behavioral healthcare, clinical research and quality in virtual therapy. The current Override directory verifies her present company affiliation; the older AbleTo office is scoped historically rather than asserted as current. The issuer board’s investor wording does not prove a personal cash contribution.

Chad Shafer is a physical therapist focused on helping patients with chronic pain rebuild movement confidence and function. At Override, he integrates movement-based rehabilitation, pain neuroscience education, and pacing strategies to reduce fear and promote long-term recovery. His approach combines evidence-based exercise with empathy and active problem-solving to help patients move beyond pain limitations.

Becky Curtis is a nationally recognized speaker and chronic pain advocate whose own experience with a spinal cord injury shaped her coaching-based approach to pain management. She pioneered a model that combines lived experience, empathy, and pain neuroscience to help patients build sustainable self-management skills and reduce reliance on opioids, which now informs Override's coaching approach.

Corey Crowley is published by Override as Head of Technology and Security. The company operates a virtual interdisciplinary chronic-pain care service spanning medicine, rehabilitation, health psychology and coaching. Further education and detailed career history are not exposed by the current own directory and are not inferred.

Dr. Valeria Martinez-Kaigi is a clinical health psychologist with expertise in chronic pain, behavior change, and the integration of psychological and medical care. She serves as Chief of Health Psychology at Override Health and is certified in Pain Reprocessing Therapy (PRT). Dr. Martinez-Kaigi’s work focuses on helping patients rewire pain pathways, enhance resilience, and regain function through biopsychosocial treatment models. The issuer inconsistently labels her PsyD and PhD/MS across its two directories; her precise doctoral credential is not independently resolved.

Adam Woeller, CPA, is Override’s head of finance and HR. His own AccelerateAccounting biography identifies founding that accounting business in2021, earlier finance leadership in high-growth manufacturing, technology and real-estate companies, a UNC economics bachelor degree and a UNC Kenan-Flagler accounting master degree. His consulting firm listsOverride among clients; no assumption of sole full-time employment is made.

Heather Bookman is published by Override as Head of Clinical Operations. The company operates a virtual interdisciplinary chronic-pain care service spanning medicine, rehabilitation, health psychology and coaching. Further education and detailed career history are not exposed by the current own directory and are not inferred.

Dr. Christina Le-Short is a double board-certified anesthesiologist and pain medicine physician who leads clinical services at Override Health. She designs team-based medical, psychological, and rehabilitation pathways that improve outcomes for people with chronic pain.

Sabrina Mason is Override’s head of product and business operations. Her own public professional profile confirms the company affiliation, study at BostonUniversitySchoolofPublicHealth, and LeanSixSigma/quality-improvement certificates issued through BostonUniversity, BostonChildren’sHospital andIHI. Further career details from secondary biographies are not asserted.

Kili Preitauer is CEO and a board member of Override. Its July10,2024 own appointment announcement identifies earlier TuesdayHealth/Valtruis work and over20years in managed care, healthcare technology and services, including business development and client relationships. Her current own writing describes leading a multidisciplinary chronic-pain telehealth practice. No independent clinical-outcome claim is inferred.

Override is the chronic-pain care brand of Global Pain Center Corp., a Delaware corporation formed in 2021 (SEC CIK1917600/EIN87-2545509). Its current privacy policy identifies the legal operator and Dayton, Ohio contact. The company delivers virtual interdisciplinary care combining pain medicine, physical therapy, health psychology and pain coaching, including pain-neuroscience education and behavioral approaches. It was founded by Jennie (Jennifer) Shulkin and former US Veterans Affairs secretary David Shulkin; Kili Preitauer became CEO in July2024 and remains on the current published leadership/board directory. The public professional roster includes operational leaders, clinical advisers, directors/observers and a multidisciplinary care-provider network; current public-directory roles are separated from historical founder offices and hidden published clinical biography templates. Pain reprocessing and clinical outcome statements are company claims, not independently verified treatment efficacy or AI product certification. Its USD3.5M initial seed was co-led by7wireVentures and MartinVentures with SignalFire and ConfluentHealth; an issuer announcement confirms a2023 Esplanade seed extension. SEC2023 cumulative offering subscriptions include the original2022 offering and are not a separate new4.5M round. Distinct2025 and2026 offerings report actual securities sold below their offering targets, with allocations undisclosed. Override is unrelated to cybersecurity company CrashOverride.

Bhavan Shah is listed in Isaac Health’s public care-team directory as Neurologist. The issuer biography describes Dr. Bhavan Shah, MD, MPH is a neurologist with clinical interests in epilepsy, clinical neurophysiology, general neurology, teaching and overall quality improvement of patient care. He completed his Doctor of Medicine at Avalon University School of Medicine his residency at Neurology Weill Cornell Medical. He was also a Neurophysiology fellow at Weill Cornell Medical. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Curtis Deloney is listed in Isaac Health’s public care-team directory as Neurologist. The issuer biography describes Dr. Curtis Deloney, MD, MPH, MSc is a board-certified neurologist and sleep physician with over 13 years of clinical experience. He completed his Doctor of Medicine at WakeMed Raleigh Campus, followed by an internship in Internal Medicine and residency in Adult Neurology at Vanderbilt University Medical Center. Dr. Deloney also completed a fellowship in Sleep Medicine at the University of Michigan Health System. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Hassan Ali Khan is listed in Isaac Health’s public care-team directory as Physician. The issuer biography describes Dr. Hassan Khan, DO is a board-certified physician in Internal and Obesity Medicine with a passion for comprehensive, patient-centered care. Dr. Khan has dedicated his career to advancing the health and well-being of adults across the spectrum of general medicine, metabolic disease, and geriatric medicine. His journey in medicine has been shaped by a deep commitment to supporting patients not only in clinical settings but also in their homes and communities, where the foundations of health are built and sustained. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Irene Viñas is listed in Isaac Health’s public care-team directory as Lead Psychometrist. The issuer biography describes Irene Viñas is a specialized psychologist and psychometrist with over 15 years of experience dedicated to the evaluation and treatment of individuals with neurocognitive disorders. She is certified to administer a wide variety of cognitive tests for comprehensive patient assessment. A key part of her work also involves providing crucial support and psychoeducation to families, offering practical strategies for managing challenging situations and emotional support. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Jack Tsao is listed in Isaac Health’s public care-team directory as Behavioral Neurologist. The issuer biography describes Dr. Jack Tsao, MD, DPhil, MBA is Professor of Neurology at Rutgers New Jersey Medical School and Director of the Center for Memory and Brain Health. Previously he was Professor of Neurology, Pediatrics, and Anatomy & Neurobiology at the University of Tennessee Health Science Center and Chief of Neurology and Director of the Polytrauma/OIF/OEF Clinic at the Memphis Veterans Affairs Medical Center, both in Memphis, TN and the Dr. Edwin Kolodny Professor of Neurology at the NYU Grossman School of Medicine in New York, NY. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Richard Orlan is listed in Isaac Health’s public care-team directory as Geriatrician. The issuer biography describes Dr. Richard Orlan, MD is an accomplished provider of care to seniors. He earned his Doctor of Medicine from Ross University School of Medicine and completed his internship and residency in Internal Medicine at Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals’ Elmhurst Hospital Center, followed by a fellowship in Nephrology at the same institution. He is a Diplomate of the ABIM with active certifications in Geriatrics and Hospice and Palliative Medicine. Dr. Orlan previously served as the Medical Director of VHA CBOC. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Samantha Meshack-Hart is listed in Isaac Health’s public care-team directory as Neurology Nurse Practitioner. The issuer biography describes Samantha Meshack-Hart is a neurology nurse practitioner with over 20 years of healthcare experience. As an Advanced Practice Provider for over a decade, she has a wealth of experience spanning hospital medicine, inpatient palliative care, community based geriatrics, and outpatient geriatrics and palliative care. She is passionate about helping families navigate the community health system to leverage care that supports aging well. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Sulagshan Mahendrarajah is listed in Isaac Health’s public care-team directory as Neurologist. The issuer biography describes Dr. Shaun (Sulagshan) Mahendrarajah, MD is a neurologist with a special interest in neurodegenerative disorders and stroke. He was a resident doctor at the University of Iowa Hospitals and Clinics and implemented the Parkinson’s program and DBS program at Asante Physician Partners in Oregon. Dr. Mahendrarajah received his medical degree from Saint James School of Medicine and has expertise in treating dementia, Alzheimer’s dementia, Parkinson’s disease, among other conditions. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Ani Chamesian is listed in Isaac Health’s public care-team directory as Speech-Language Pathologist (SLP). The issuer biography describes Ani Chamesian is a Speech-Language Pathologist with diverse experience across adult acute care, skilled nursing facilities and home health. At Isaac Health, she provides thoughtful, adaptable care to adults with a range of communication, voice, swallowing and cognitive needs. Ani brings a person-centered approach to her work, grounded in empathy, curiosity, and a genuine interest in others. She enjoys learning about people’s passions, hobbies, and the unique details of their lives. She recognizes that communication is closely tied to identity and autonomy, and prioritizes helping patients build insight into their strengths and challenges. She encourages reflection and active participation in the therapeutic process, supporting individuals in becoming more independent and ultimately their own “therapist.” Her approach emphasizes practical, real-world application of skills so strategies are meaningful and transferable. Above all, her goal is to help patients build confidence, independence, and engagement in their daily lives through a collaborative and evolving therapeutic process. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Bradley Peet is listed in Isaac Health’s public care-team directory as Behavioral Neurologist and Neuropsychiatrist. The issuer biography describes Bradley T. Peet, MD is a physician specializing in Behavioral Neurology and Neuropsychiatry. Dr. Peet completed his MD at LSU School of Medicine in New Orleans, LA. He went on to complete a residency in psychiatry at LSU Health and a fellowship in Behavioral Neurology at the UCSF Memory and Aging Center in San Francisco, CA. He has experience in treating patients with cognitive impairment and dementia, particularly those with frontotemporal dementia (FTD). Why I joined Isaac Health Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Gabor Ferenczy is listed in Isaac Health’s public care-team directory as Geriatrician. The issuer biography describes Dr. Gabor Ferenczy is an accomplished and compassionate internist and geriatrician, with board certifications in both specialties. He earned his medical degree with Summa Cum Laude honors from Semmelweis University in Budapest, Hungary, a reputable European institution recognized for its high academic standards and rigorous training programs. Following his graduation, Dr. Ferenczy refined his skills during a competitive residency training program in internal medicine at the prestigious NewYork-Presbyterian Queens Hospital. Driven by his passion for geriatric care, Dr. Ferenczy completed a fellowship in geriatric medicine at the esteemed University of Florida in Gainesville, FL. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Maria Guadalupe Ramos Mendez is listed in Isaac Health’s public care-team directory as Geriatrician. The issuer biography describes Dr. Maria G. Ramos Mendez is a dedicated geriatrician committed to delivering holistic, patient-centered care that promotes independence, dignity, and improved quality of life for older adults through personalized treatment and collaboration within interdisciplinary teams. She earned her Medical Doctor (M.D.) degree from the University of Guadalajara, Mexico, and completed her foundational Internal Medicine Residency at Lincoln Medical Center in New York City (affiliated with NYC Health + Hospitals and Weill Cornell Medicine). She attained specialized training through the Geriatrics Fellowship Program at Weill Cornell Medicine/New York Presbyterian Hospital. Her practice experience began in Texas as an Attending Physician at Austin Geriatric Specialists, followed by clinical roles in New York City, including serving as an Attending Physician at The New Jewish Home (part of the Mount Sinai Hospital/Hospitalist Department), and later holding the dual role of Assistant Professor/Attending Physician in the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Maria G. Ramos Mendez subsequently returned to Austin, Texas, providing care for adult and geriatric patients as an Attending Physician at both the WellMed Senior Clinic at Ben White and SUVIDA Health Clinic. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Nadir Bilici is listed in Isaac Health’s public care-team directory as Neurologist and Head of Lifestyle Medicine and Brain Health. The issuer biography describes Dr. Nadir Bilici, MD, DipIBLM is a double board-certified neurologist and lifestyle medicine physician, clinician-innovator, and educator dedicated to transforming neurological care through a multidisciplinary approach that blends evidence-based medicine, lifestyle modification, and digital health. He is currently an Assistant Clinical Professor at Mount Sinai Health System where he serves as a neurohospitalist. As a faculty neurologist at Isaac Health, he practices cognitive neurology and directs the Lifestyle Medicine for Better Brain Health program. While at the University of Pennsylvania he facilitated a Culinary Medicine elective dedicated to teaching medical students about food-as-medicine approaches to clinical care. He completed residency in neurology at NYU Langone Health where he served as chief resident. As a resident, he participated in a 3 week global neurology trip to Tamale, Ghana to teach residents and faculty about neurology and improve hospital practices. He directs an independent practice focused on Preventive Neurology and Lifestyle Medicine. Prior to his career in medicine, he was Product Manager at Azumio where he developed several top health & fitness mobile apps. He has authored several peer-reviewed academic papers and contributed to books about culinary medicine, evidence-based education, and neurodegenerative disease. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Patrick Hou is listed in Isaac Health’s public care-team directory as Psychiatrist. The issuer biography describes Dr. Patrick Hou, MD, MPH has been a practicing clinical psychiatrist since 2011. Dr. Hou completed his residency in general psychiatry at Mount Sinai Beth Israel and a fellowship in consult-liaison psychiatry at Memorial Sloan Kettering Cancer Center in New York City. Since completing training, he has worked as a consult-liaison psychiatrist in a hospital for many years, providing recommendations for management of psychiatric concerns and symptoms for patients who are medically hospitalized. During this time, Dr. Hou worked with many older patients and people experiencing cognitive disorders and their loved ones to provide the best management possible during the hospitalization and also referral to services after they were discharged. Dr. Hou also has extensive experience working in telehealth to provide services to clients in their own homes. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Swatiben Patel is listed in Isaac Health’s public care-team directory as Lead Advanced Practice Provider. The issuer biography describes Swati is an Adult Nurse Practitioner with a long-standing passion for caring for people with neurological conditions, especially dementia and Alzheimer’s disease. She brings nearly 20 years of nursing experience to her role, along with a calm, compassionate approach that helps patients and families feel supported every step of the way. She holds a Master of Science in Nursing (Adult Nurse Practitioner) from the University of North Carolina at Charlotte and a Bachelor of Science in Nursing from the University of North Carolina at Chapel Hill. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Joel Salinas is listed in Isaac Health’s public care-team directory as Behavioral Neurologist; Chief Medical Officer and Co-Founder of Isaac Health. The issuer biography describes Dr. Joel Salinas, MD, MBA, MSc, FAAN, is Founder and Chief Medical Officer of Isaac Health, a tech-enabled brain health platform and telehealth service that works with health plans and systems to identify and manage conditions related to brain health and dementia across populations. Dr. Salinas is a behavioral neurologist, scientist, speaker, and author. He is an expert in clinical and population health approaches to brain health, helps to lead the American Academy of Neurology’s National Brain Health Initiative, and has led NIH-NIA-funded research to understand psychosocial determinants of health and harness these insights to preserve healthy cognitive function at the population level. He has authored over 50 peer-reviewed academic papers and contributed to nine books on evidence-based practice of neurology. He and his work have been featured often in prominent national and international media outlets. Clinical provider listings concern access through the platform and do not establish employment by its technology-company legal issuer.

Isaac Health is the operating brand of 2GHealth Inc., a Delaware health-technology corporation formed in2021 (SEC CIK1924493). Its AI-enabled brain-health platform supports identifying cognitive concerns, coordinating specialist assessment and ongoing dementia care, and connecting patients and caregivers to virtual neurology, psychiatry, geriatric medicine, cognitive therapy and navigation services. The published co-founders are CEO Julius Bruch and chief medical officer Joel Salinas. The issuer’s legal terms explicitly distinguish the technology/administrative platform from separately operated medical groups, including Isaac Health Florida PA, Brain Health Medical PC and Isaac Health PC; the platform company does not own these medical groups, and clinical directory listings are qualified provider affiliations rather than automatic corporate employment. Its current published team contains administrative leaders, clinicians, advisers and care navigators. Clinical diagnoses and treatment decisions belong to the independent providers; marketing outcomes, AI screening patents and access to approved medicines do not prove FDA approval or independently established efficacy of this platform. The issuer announced completion of aUSD5.7M seed onJanuary29,2024 co-led by Meridian Street Capital and B Capital, with Primetime Partners, Co-Found Partners, VU Venture Partners and AirAngels. A separate SeriesA announcedAugust14,2025 was led by Flare Capital Partners with Industry Ventures, Black Opal Ventures and returning Meridian Street, B Capital and Primetime. The issuer announced rounded10.5M; its August19,2025 SEC notice reports the same fully sold equity offering at exactUSD10,443,495.82, with zero remaining. The first-sale date is not the final close date. A2024 SEC notice reports5,766,996 sold against a larger6,865,751 offering, qualified alongside the same5.7M seed rather than added as a second round. An earlier2022 filing reports1,265,000 sold of option/right securities toward1.3M, with35,000 remaining; instrument detail, named buyers, disbursement and final close remain undisclosed. Public cumulative funding16.3M and inconsistent rounded figures are not arithmetically converted into additional cash events.

Melissa Pegus is the person published in UpVentures' current Capital-filtered team directory, with the affiliation SCM, UpVentures Capital. SCM refers to the group's Simple Certified Mail business. The directory provides an authentic named portrait but does not specify a Capital job title, employment dates or investment committee authority. Her affiliation is recorded with that limitation.

Michael Sciotti co-founded UpVentures Holdings and leads strategic investments and community development work. His own group biography describes financial management, private equity due diligence and real estate projects, including Rock City Centre in Little Falls. He studied economics and management at Wells College and finance at the University of Rochester's Simon Business School. The affiliation is group investment leadership, with no unpublished Capital-unit employment dates inferred.

Nasir Ali is a co-founder of UpVentures Holdings and an entrepreneur, investor and community organizer. His primary group biography describes launching the Syracuse Technology Garden, co-founding Upstate Venture Connect with Martin Babinec, founding StartFast Venture Accelerator and managing StartFast FundII. He studied physics at Princeton and earned an MBA at Yale. This role records published group leadership; it does not assert direct employment by the Capital unit or duplicate those outside entities' investments.

UpVentures Capital is the investment and business-operating unit of the US UpVentures group based in Little Falls, New York. Its current primary site focuses on acquiring profitable lower-middle-market businesses, especially B2B software, technology-enabled services and managed services, and supporting their operations and growth. It also describes selective early-stage and pre-IPO participation through partner VC/family-office networks and SPVs. Founder Martin Babinec's own biography identifies his creation of UpVentures Capital; current group leaders' affiliations are qualified separately from direct unit employment. The Capital-filtered published roster identifies Melissa Pegus, while Nasir Ali and Michael Sciotti are published group investment leaders. This is distinct from UP Ventures Group in the UK, the Italian UpVentures venture studio and Upfront Ventures. SleepSpace's issuer crowdfunding materials explicitly identify UpVentures among prior venture backers; exact subscribing legal vehicle, closing date and ticket size are unpublished. The current portfolio page exposes no named investments in its fetched public body, and no independently established LP fund corpus is imported.

Edgard Capdevielle joined Alethea’s board as an independent director effective December9,2025. The issuer’s announcement describes his prior leadership at Imperva and Data Domain and his work scaling Nozomi Networks. He was Nozomi CEO when that announcement was issued; his newer own public departure statement says he handed the CEO role to co-founder Andrea Carcano and moved to executive advisor. The exact transition day is not established here, and the old CEO title is not asserted current.

Asa Berolzheimer is Alethea’s Chief of Staff. He joined the company in June 2021, a company-joining month rather than a verified start date for the current title. His work connects communications, marketing, sales, product, finance and operations as the company expands.

Kayla Ryan is listed as Vice President of Communications in Alethea’s current directory, while her detailed biography uses Head of Communications. She manages external communications, media engagement, research storytelling and events. Her earlier experience includes serving as a vice president in 5W’s business-to-business technology practice across cybersecurity, AI, cloud and financial technology.

Nancy Teegarden is Alethea’s Vice President of Finance and Operations. Her published career spans more than 25 years across major public companies and growth-stage technology businesses. She began at Deloitte before focusing on finance and operational discipline for technology startups.

Yi Becker is Alethea’s Vice President of Technology. She leads engineering for Artemis, including product development, data infrastructure and platform reliability. Before Alethea she managed product-engineering teams in startups and larger companies, with particular experience in cybersecurity.

Brian Besanceney is Alethea’s Principal Advisor. He previously served as chief communications officer at Boeing and Walmart and held senior positions at Disney and the White House. He advises on communications, crisis response and organizational change; the published advisory position does not establish employee status or a personal investment.

Glenn Lemons is Alethea’s Chief Customer Officer, responsible for customer success and intelligence engagement. He previously led intelligence and customer-facing functions at Flashpoint, cyber intelligence at Citi, and cyber analysis at the US Department of Homeland Security. His biography also describes 22 years of military service and involvement in establishing US Cyber Command.

Peter Trennum is Alethea’s Chief Product and Technology Officer and Chief AI Officer. He oversees product, engineering and AI strategy, drawing on prior leadership experience at Microsoft, Technicolor and Age of Learning. His career includes cybersecurity leadership and integrating technology organizations following acquisitions.

Lisa Kaplan founded Alethea in 2019 and serves as its CEO. She directs the company’s software and intelligence work on disinformation, manipulation and online organizational risk. Her own biography describes policy briefings for US, NATO, EU and G7 officials and a degree from Colby College.

Alethea Group, Inc., branded Alethea, is the US artificial-intelligence risk-intelligence software company operating alethea.com. Its own legal privacy notice and terms identify the corporation; historical Alethea Group branding at aletheagroup.com refers to the same issuer. It is distinct from the unrelated Alethea AI cryptocurrency/NFT platform. Lisa Kaplan founded the company in2019. Its Artemis platform combines machine learning with analyst intelligence to identify, assess and respond to online narrative threats, disinformation, coordinated manipulation and threats of physical violence affecting companies, nonprofits and public institutions. Current published products include Risk Radar, Artemis for Security and agentic AI mitigation/takedown tools. It serves communications, cybersecurity and physical-security teams; reported detection performance, business outcomes and attribution assessments are company claims, not independent guarantees. The company’s AI software scope is established by its own product descriptions and GV’s explicit AI portfolio classification. Its current leadership directory publishes eight people, including a separately qualified principal advisor. A December9,2025 announcement adds independent director Edgard Capdevielle. Public named leadership is recorded without implying a complete private staff census. Primary sources confirm a USD10M SeriesA announced November2,2022 led by Ballistic Ventures and a USD20M SeriesB announced April9,2024 led by GV with Ballistic Ventures and Hakluyt Capital participating. USD34M cumulative funding reported in2024 is not an additional financing or proof of an undisclosed seed round’s date, ticket or participants. A January4,2022 AFWERX SBIR PhaseI contract announcement is recorded separately as a non-equity award of undisclosed amount, without asserting cash disbursement or a contracting legal entity. Individual investor representatives are not personal buyers unless explicitly identified.

Donnchadh Cullinan is Enterprise Ireland’s divisional manager for Technology, Services and Consumer, appointed in July 2026. His agency experience includes enterprise solutions and work with digital technology, fintech, software, education and professional-services businesses. He holds an aeronautical engineering degree from the University of Limerick and a technology-management master’s degree from University College Dublin.

Garrett Murray is Enterprise Ireland’s divisional manager for Investment Solutions, covering venture funding, new investments, scaling finance and the direct equity portfolio. He joined from Forfás in 2006 and has held strategy and client-solutions responsibilities, including work establishing Client Solutions in 2025.

Mary Kinnane is Enterprise Ireland’s divisional manager for People and Global Markets, appointed in July 2026. Her published role combines the agency’s international network and people responsibilities. She is a University College Dublin graduate with extensive agency experience supporting startups, scaling companies, exports and leadership development.

Ann O’Connor is an Enterprise Ireland board member, appointed in March 2026, and a pharmacist with extensive pharmaceutical and medical-device regulatory experience. Her published career includes the Health Products Regulatory Authority, Grifols and Jazz Pharmaceuticals. She previously directed HPRA medical-device and human-product registration and licensing functions and now advises on quality and regulation.

Anne Cusack is an Enterprise Ireland board member, appointed in March 2026. She co-founded and previously led Critical Healthcare, sold in 2021. Her published professional experience spans healthcare entrepreneurship, technology, certified directorship and public and educational governance.

Anne Lanigan is Enterprise Ireland’s divisional manager for Local Enterprise and Regions. She joined the agency in 2003 and has held international, startup, software and export-development leadership roles, including Eurozone, Central and Eastern Europe and Japan responsibilities. Older biography wording assigning Technology and Services is historical.

Carol Gibbons is Enterprise Ireland’s divisional manager for Client Solutions in the current directory. Her agency career spans research commercialisation, technology businesses, startup and scaling-company support and international work in London and the United States. Older narrative assigning regional and local enterprise responsibilities is historical rather than her current remit.

Joe Healy is Enterprise Ireland’s divisional manager for Research, Innovation and Infrastructure in the current directory. He joined the agency in 1997 and has worked in enterprise development, food, equity and legal functions. He previously served as board secretary in 2013–2017 and 2020–2022. Older narrative referring to a Global Markets remit is historical.

Kevin Sherry is an Enterprise Ireland executive director. The current directory assigns People and Global Markets, Research, Innovation and Infrastructure, and Transformation, Cyber and IT. His agency career includes global business development, high-potential startup and accelerated-growth leadership and service as interim chief executive in 2025. Older narrative descriptions of his remit are retained only as historical career evidence; the current directory title governs his present role.

Leo McAdams is Enterprise Ireland’s divisional manager for Advanced Manufacturing, Construction and Life Sciences. His agency career began with marketing work in Paris in 1996 and subsequently included leadership of Spain and Italy offices, equity investment, fintech, business-process outsourcing and ICT portfolios. Earlier finance and investment-services remits are historical.

Mark Christal is Enterprise Ireland’s executive director for Sectoral and Client Solutions, appointed in January 2026. His earlier agency leadership includes food, sustainability, regional enterprise and entrepreneurship responsibilities. He holds a business master’s degree from UCD Smurfit. The current directory and January 2026 appointment release give different agency joining years; neither year is asserted as settled.

Paul McKeown is an Enterprise Ireland executive director responsible for Investment Solutions and Finance in the current directory. He joined as chief financial officer in 2017 and became an executive director in 2019. His earlier career includes finance leadership at St Vincent’s Hospital and KPMG. He is a Fellow of Chartered Accountants Ireland and holds commerce and accounting qualifications from University College Dublin. Older directory narrative describing other remits is historical.

Tom Cusack is Enterprise Ireland’s divisional manager for Food, Drink, Nutrition and Climatetech. His agency career includes marketing work in Paris from 1998 and regional leadership covering Benelux, New York and Asia Pacific. Earlier professional experience includes the World Health Organization in Geneva and private-sector investment-development work in Paris.

Christine Cullen is an Enterprise Ireland board member and co-founder of Vision-net.ie and Solocheck.ie. Her current agency biography identifies her as managing director of CRIF Vision-net. Her experience combines company information, financial services and business leadership; she holds a UCD master’s degree in leadership and management.

Dermot Mulligan serves on Enterprise Ireland’s board. His published government role is Head of the Indigenous Enterprise Division, held since January 2025. His earlier public-service responsibilities include workplace regulation, economic migration, innovation and investment and work across government departments.

Des Power is an Enterprise Ireland board member and chairs its Investment Portfolio Review Committee. His technology leadership experience includes Google, Fitbit, Harman and Philips. His published profile describes advisory and nonexecutive work and an INSEAD director qualification completed in 2024.

Lucinda Woods serves on Enterprise Ireland’s board and advises startup and scaling businesses on finance and strategy. Her published career includes strategy and business development leadership at The Restaurant Group and finance work at Paddy Power, now Flutter. She qualified as a chartered accountant at KPMG and holds an Oxford degree and a Harvard MBA obtained as a Fulbright scholar.

Mark WJ Ferguson serves on Enterprise Ireland’s board. He was Director General of Science Foundation Ireland and Ireland’s Chief Scientific Adviser from 2012 to 2022, and chaired the European Innovation Council board from 2018 to 2023. His current published profile includes Catalyst board service and work with the US–Ireland research and development partnership; the former SFI post is historical.

Conor Hanley serves on Enterprise Ireland’s board and is chief executive of FIRE1, a connected medical-device company. He previously worked in chronic-disease and cardiology businesses at ResMed and co-founded and led BiancaMed, acquired by ResMed in 2011. His qualifications include a doctorate in chemical engineering from the University of Pennsylvania, an INSEAD MBA and a University College Dublin engineering degree.

Dónal Rooney is an Enterprise Ireland board member and chartered accountant. His published career includes Group CFO responsibilities at NAMA and Amaris Hospitality and senior finance work involving public institutions, private equity-backed businesses, corporate transactions and treasury.

Jenny Melia is Enterprise Ireland’s chief executive and a board member. The government board register identifies Jennifer Melia, appointed July 14, 2025. Her agency career includes Chief Client Officer and executive leadership in startup support, technology and research commercialisation. She holds chemistry undergraduate and doctoral qualifications from University College Dublin.

Jim Woulfe chairs Enterprise Ireland. The agency announced his appointment in February 2026; the government board register records James Woulfe from February 12, 2026. He spent 42 years at Dairygold and was its chief executive from 2009 to 2021. His published career spans agricultural enterprise, export businesses and board leadership.

Terri Moloney serves on Enterprise Ireland’s board. Her published experience covers business strategy, operations, people and organisational culture, with career experience at Kerry Group, Laing O’Rourke, Boston Scientific, Hilti and Salesforce.

Rishi Sikka is a physician and healthcare executive who announced a LifeForce Capital venture-partner affiliation in2022 and was interviewed in that capacity in July2023. That dated LifeForce affiliation is recorded as historical, without asserting current salaried membership. Earlier he led system enterprises at Sutter Health and held senior clinical transformation responsibilities at Advocate Health Care. His career combines clinical training, healthcare operations and entrepreneurship. Presbyterian’s own2025 donor-impact publication names him president and CEO and supplies his authentic current portrait. Current outside leadership does not establish any personal investment allocation.

Sander Duncan is a healthcare investor and operator whose LifeForce Capital general-partner tenure is described in Distributed Ventures’ current public advisory biography. The2020 LifeForce FundII offering filing separately lists him as a managing director of the general partner. His current published primary affiliations are founder and CEO of Sespe Health Holdings and partner at Endurance Companies; the LifeForce role is recorded as historical rather than assumed current employment. His earlier work included Pager, Cleveland Clinic and Northwell Health, and he advises CareFirst BlueCross BlueShield on investments. Endurance publishes his authentic named portrait.

Jamie Daves identifies himself as a venture partner at LifeForce Capital on his own current biography. He also serves as managing director and board member of the Institute for New Economic Thinking and co-founded the Neurorights Foundation, connecting his work to brain-data research and advocacy. Earlier he co-founded Current TV with Al Gore and invested at City Light Capital and Platform Equity, with additional experience in public policy and digital media. His education includes a Stanford MBA and University of Pennsylvania BA. These outside affiliations explain his published career; they do not establish additional institutional or personal checks.

Adam Pelavin is a LifeForce Capital partner, promoted in June2023 after serving as adviser and venture partner from June2016. Orgenesis’2026 issuer filing says he co-leads LifeForce’s AI-plus-health and neuroscience strategies, investing in software-driven drug development and care delivery. Earlier he co-founded Comprisma to address healthcare financial incentives, worked in education policy and research, and earned a mathematics degree from Pomona College and an MFA in fiction from the University of California Riverside. Orgenesis publishes his named director portrait; the corporate board affiliation is evidence for his biography, not an inferred personal cash investment.

John Kenneth Noonan, commonly named John Noonan, is the founder of LifeForce Capital and managing director and owner of its legal adviser, LifeForce Capital Management LLC. The March 18, 2026 Form ADV reports the management and ownership position since November 2015. UCSF’s own advisory biography describes earlier work as a senior adviser at the US Department of Health and Human Services and vice president of corporate development at Gerson Lehrman Group, as well as a Harvard undergraduate degree, Harvard MBA and Yale law degree. Rock Health’s October 2016 retrospective describes the first LifeForce fund and its initial investments in Advantia, Second Genome and Able Health. Floreo independently publishes his founder/general-partner biography and authentic named board portrait. Institutional affiliations do not imply personal investment tickets.

Robert Schotzinger is a biotechnology executive with research, development and financing experience. He co-founded and led Viamet Pharmaceuticals through its acquisition and is published by Eldec Pharmaceuticals as chairman and acting CEO.

Cape Fear BioCapital is an early-stage venture capital firm focused on building and financing therapeutics and related human-health technologies rooted in North Carolina. It writes first institutional checks at pre-seed and Seed and can also join later-stage syndicates for North Carolina companies. The firm works with university-linked science and founders to develop investable companies, recruit experienced leadership, establish proof-of-concept data and advance programs toward clinical development. Its published approach covers both multi-indication platforms and single-asset programs, emphasizing differentiated biology, novel modalities and companies approaching an investigational-new-drug filing. Published holdings span oncology drug discovery and RNA therapeutics, small-molecule cancer treatments, respiratory peptide medicines, cardiothoracic devices and AI-assisted cell and organoid manufacturing. A partnership with Parexel provides access to clinical-development and regulatory expertise through the Parexel Biotech Incubator. The firm’s legal management company is Cape Fear BioCapital Management Company, LLC; its Delaware FundI limited partnership and fund general partner are distinct entities. Moore Strategic Ventures anchors the fund, while Parexel and individual operators are investors and strategic partners rather than automatically firm employees.

Ed Field brings biotechnology operating and leadership experience to Cape Fear BioCapital. His work includes fundraising, moving therapeutics into clinical development and forming companies from university research.

Jimmy Melton has built and led life-sciences businesses across North Carolina. His experience includes managing Carolina Research Ventures and investing in early-stage university-linked companies.

John Bamforth advises life-sciences businesses after leading Eshelman Innovation and spending three decades at Eli Lilly, including US and global marketing leadership. Humacyte’s April2026 proxy reports his Cape Fear strategic-adviser affiliation since August2025.

Sarah GiaQuinta, MD, is identified as Parkview Health senior vice president for community impact in its December16,2025 primary announcement of the Parkview/NotreDame/1842Fund AIrural-health venturecollaboration. Earlier Parkview pages describe community-health/equity responsibilities. Her published role is institutionalcommunityimpact leadership, not a verified generalpartner title or personalinvestment. Individuallyassociated headshot not established from the current announcement.

Dan Starr is identified as chairman of Parkview Health’s board of directors in its official2026factsheet. Full public career biography and an individuallyassociated authentic institutional headshot were not established from the currently available Parkview board directory; no inferred personalcash or exactappointmentday.

Kira Voelker is listed on Parkview’s current Health Services and Informatics Research team. Research Assistant Education Bachelor of Science, Psychology, and Bachelor of Arts, Comparitive Literature, Purdue University, West Lafayette, Indiana Curriculum Vitae Active projects CCBHC-IA: Reimagining Mental Healthcare

Michael Mirro, MD, is Parkview’s chief academic research officer, appointed2014, and senior vice president identified in the current Mirro HSIR directory. A cardiologist and clinical research leader, he joined Fort Wayne Cardiology in1981 and has taught at Indiana University School of Medicine since1982. He earned his undergraduate degree at Loyola University Chicago and medical degree at Indiana University. The Mirro Center opened2015 with a leading gift from him and his wife. His Indiana University trustee service during2014–2023 is historical.

Shahar Eidelman supports CommonSpirit venture diligence and transaction compliance. His ministry career began with predecessor CHI in2016. Previously he led finance and compliance at international development organisations. He holds Maryland finance and economics degrees and a Denver executive MBA.

Anuradhika A supports CommonSpirit Ventures’ investment strategy, sourcing, diligence and portfolio management and leads strategic partnerships. Her earlier experience includes digital-health startups and academic medical systems. She studied healthcare administration at Washington and trained in pharmacy at Rajiv Gandhi University.

Christine Brocato co-leads CommonSpirit innovation in care automation, mental health, transportation and social determinants of health. Her earlier leadership includes Genentech, Abbott Vascular and Kaiser Permanente. She holds a Georgetown MBA and Santa Clara combined-sciences degree.

Joicy Lu supports strategic finance, transactions and venture-investment diligence at CommonSpirit. Previously a senior manager at EY and Deloitte, she advised on valuation and fairness opinions. She holds Southern Methodist graduate degrees, including an MBA, and has a journalism background.

Manoja Lecamwasam leads CommonSpirit intellectual-property strategy and life-science and device innovation. Previously a Dignity Health innovation executive, she helped establish the Precision Medicine Alliance. Her education includes a Tufts molecular-microbiology doctorate and graduate business and biology study.

Matt Wagner supports investment diligence for CommonSpirit Ventures. Earlier leadership included SSM Health investments, Anheuser-Busch and Health Capital Consultants. He holds Missouri finance and MBA degrees, a CFA charter and an investment-performance measurement qualification.

Sean Senn leads life-science innovation and intellectual property at CommonSpirit. He co-founded Immix Biopharma and Accelerator AIX and previously practised patent law. His qualifications include a UCLA MBA, San Diego law degree and molecular-biology study.

Venkata Naveen Kumar Udumula is listed on Parkview’s current Health Services and Informatics Research team. Research Data Engineer Education Master of Science, Computer Science, Purdue University Fort Wayne, Indiana. Bachelor of Technology, Information Technology, Jawaharlal Nehru Institute of Technology, Kakinada, India. Curriculum Vitae

Paul Black is a CommonSpirit trustee, PMB Global Ventures principal and New Mountain Capital executive advisor. Previously Allscripts CEO and Cerner COO, he has extensive healthcare-technology operating and board experience. He studied at Iowa State and the University of Iowa.

Rich Roth leads CommonSpirit’s strategic innovation, testing and scaling services, partnerships and technologies to improve care quality, access and cost. He co-manages its strategic investment fund. He holds Minnesota healthcare-administration and West Chester public-health degrees.

Antoinette Hardy-Waller chairs CommonSpirit’s Board of Stewardship Trustees, effective July1,2025. A clinician and entrepreneur with acute and post-acute leadership experience, she founded The Leverage Network to increase African American representation in healthcare governance.

Carolina Reyes is a CommonSpirit trustee, practising maternal-fetal medicine specialist and UC Davis associate clinical professor. She chairs the California Health Care Foundation board and has served as a Catholic Health Association trustee.

Gary Kaplan is a CommonSpirit trustee and board-certified internist. He chaired and led Virginia Mason Health System from2000 to2020 and co-led Virginia Mason Franciscan Health in2021. His work centres on care quality, safety, leadership and governance.

Gary Yates is a family physician and CommonSpirit trustee. He is a partner at Press Ganey Strategic Consulting, advising healthcare organisations on patient, member and employee experience.

Linda Medler is a CommonSpirit trustee and retired US Air Force brigadier general. Previously a US Cyber Command director and Raytheon Missile Systems chief information security officer, she founded cybersecurity consultancy L A Medler & Associates.

Patrick Steele is a CommonSpirit trustee and former Dignity Health board vice chair. His career includes executive vice president and CIO roles at Delta Dental of California and Albertsons. He advises venture-capital firm Blumberg Capital.

Peter Hanelt is a CommonSpirit trustee whose executive career includes CEO, COO and CFO roles in consumer-goods companies. His experience spans manufacturing, imports, wholesale and retail operations, including international turnarounds and restructuring.

Phoebe Yang is a CommonSpirit trustee and former general manager of AWS Healthcare. Her experience spans leadership and governance in faith-based health systems, population health, digital media, mergers and new ventures.

Rebecca Ann Gemma is a Dominican Sister of Springfield and CommonSpirit trustee. A licensed clinical social worker, she facilitates religious-congregation leadership and governance. Her career includes education, clinical therapy and service as her congregation’s prioress general.

Tammy Toscos is listed on Parkview’s current Health Services and Informatics Research team. Director and Senior Research Scientist Education Postdoctoral Fellowship, Health Services Research, Regenstrief Institute, Indianapolis, Indiana Doctor of Philosophy, Informatics, Indiana University, Bloomington, Indiana Master of Science, Computer Science, Purdue University, Fort Wayne, Indiana Bachelor of Science, Nutrition and Dietetics, Indiana University, Bloomington, Indiana Curriculum Vitae Google Scholar profile Active projects Care PLUS CCBHC-IA: Reimagining Mental Health Care Community Health Needs Assessment COVID-19 Health System and Community Support COVID-19 Long-Haul Project COVID-19 Surge Modeling Falls Scale for Inpatient Care Guideline-Directed Medical Therapy for Heart Failure Recommendations for Sharing CIED Data with Patients Completed projects Building Mental Health Resources to Inform Families Using Digital Guidance and Education (BRIDGE) Certified Community Behavioral Health Clinic Expansion Grant Medication Adherence for AFib Patients Oncology Patient Experience with Telehealth Opioid Use Disorder Mobile Response Team Opioid Use Disorder/Substance Use Disorder Care Continuum Initiative Opioid Use Disorder Treatment Modeling Rural Communities Opioid Response Program (RCORP) Implementation Rural Communities Opioid Response Program MAT Expansion Social Determinants of Health Telemental Health for Youth TytoCare Pilot

Amelia Roebuck is listed on Parkview’s current Health Services and Informatics Research team. Research Scientist Education Doctor of Philosophy, Epidemiology, UTHealth School of Public Health, Austin, Texas Bachelor of Science, Human Biology, Indiana University, Bloomington, Indiana Curriculum Vitae Google Scholar profile Active projects Community Health Needs Assessment Guideline-Directed Medical Therapy for Heart Failure Lifestyle Behaviors Before and After the Diagnosis of Type 2 Diabetes Completed projects Food Assistance and Support Team Program Evaluation Medication Adherence for AFib Patients Parkview Perinatal Center Data Review Social Determinants of Health Telemental Health for Youth

Angela Archon is a CommonSpirit trustee with experience in technology and operations. Previously chief operating officer of IBM’s Watson Health division, she held international leadership roles across engineering, business development, customer experience and supply chains.

Ellen Dauwer is a Sister of Charity of Saint Elizabeth and a CommonSpirit trustee. Her career spans religious formation, healthcare and higher-education governance, teaching mathematics and computing, educational technology, and congregation leadership.

Kathleen Sanford leads nursing practice, care coordination, education, research and virtual clinical services at CommonSpirit. Her career includes Army Nurse Corps leadership and healthcare administration. She holds nursing, management and business degrees and is a former American Organization of Nurse Leaders president.

Mitch Melfi leads CommonSpirit’s legal services, risk management, internal audit and governance. Previously general counsel at Nationwide Children’s Hospital, he studied at Ohio State and Capital University Law School. His ministry career began before CommonSpirit’s2019 operational formation.

Sheri Shapiro leads strategy, growth, partnerships and the venture programme at CommonSpirit. She joined in2023 from Trinity Health and previously worked at Chartis and Ford. She earned a Wharton healthcare-management MBA and Michigan biopsychology degree.

Terika Richardson leads CommonSpirit operations. Her earlier healthcare leadership includes Ardent Health, HCA and Advocate. She holds undergraduate and public-health degrees from the University of Michigan. CommonSpirit’s venture website additionally identifies her as a venture advisory-council member.

CommonSpirit Health is a Colorado nonprofit public-benefit corporation and tax-exempt national Catholic healthcare institution headquartered in Chicago. The operational system was formed in February 2019 through the alignment of Catholic Health Initiatives and Dignity Health; that operational year does not establish the original incorporation date of every predecessor or affiliate. Its investment arm, CommonSpirit Ventures, backs healthcare services, technology and life-science innovation, including operational AI and access to care. Synapticure’s November 19, 2024 announcement explicitly names CommonSpirit Health as a new Series A investor, and quotes its strategic-partnerships leader Anuradhika A. The parent and its internal venture platform are represented together here; the exact legal subscribing vehicle and ticket for that investment are not publicly identified. The current official leadership, trustee and venture directory identifies 31 people, with additional advisory-council functions held by five existing executives. Its website says it is investing from its fourth fund and describes a USD250 million current programme; this is not recorded as a verified external LP-fund closing or actual capital transfer. Portfolio listings distinguish direct investment, exits, and intellectual-property/technology-transfer relationships. Membership or commercial collaboration alone is not evidence of an equity investment.

Daniel Barchi leads information technology, digital innovation and security at CommonSpirit. He joined in2022 after CIO roles at NewYork-Presbyterian, Carilion and Yale. A Naval Academy graduate and former naval officer, he holds an engineering-management master’s degree from Old Dominion.

Lilicia Bailey leads CommonSpirit’s people strategy. She joined in2023 after serving as Emory Healthcare’s chief people officer, with earlier leadership at Wake Forest Baptist Health, Belk and Cox. She holds Pepperdine graduate degrees and a Spelman psychology degree.

Michael P. Browning became CommonSpirit’s chief financial officer inDecember2025. Previously OhioHealth CFO, he also held senior finance roles at ProMedica, WakeMed, Parkview and McLeod. He is a CPA with Kentucky Wesleyan accounting and Louisville MBA degrees.

Michelle Johnson Tidjani oversees CommonSpirit’s administration, governance and enterprise functions. Previously she was Henry Ford’s chief legal officer and Cleveland Clinic’s deputy legal officer. Her education includes Cornell, Detroit Mercy law and the Brown–IE executive MBA programme.

Rachel Pfafman is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead II Education Master of Business Administration, Indiana Institute of Technology, Fort Wayne, Indiana Master of Public Health, Biostatistics, Indiana University, Bloomington, Indiana Bachelor of Science, Community Health, Indiana University, Bloomington, Indiana Curriculum Vitae Google Scholar profile Active projects Care PLUS CCBHC-IA: Reimagining Mental Health Care Conversation Agents/AI Chatbots COVID-19 Health System and Community Support Diabetes Care Direct Digital Self-Harm Double Up SNAP Phone Use Efficacy Scale Development Project EMBRACE Completed projects Cyberbullying Digital Social Re-entry Oncology Patient Experience with Telehealth Opioid Use Disorder Mobile Response Team Opioid Use Disorder/Substance Use Disorder Care Continuum Initiative Opioid Use Disorder Treatment Modeling Rural Communities Opioid Response Program MAT Expansion TytoCare Pilot Usability and Acceptance of Patient Check-in Kiosks

Stephanie Pruitt is listed on Parkview’s current Health Services and Informatics Research team. Supervisor and Project Lead II Education Master of Science, Nursing Leadership and Management, Western Governors University Bachelor of Science, Nursing, Western Governors University Curriculum Vitae Google Scholar profile Active projects Community Health Needs Assessment Guideline-Directed Medical Therapy for Heart Failure Recommendations for Sharing CIED Data with Patients Completed projects Enhancing Implementation of Lifestyle Change Specialists within Cardiac Rehabilitation to Enhance Behavior Change for Individuals with Comorbidities Parkview Perinatal Center Data Review

Thomas Kopfensteiner leads CommonSpirit’s mission, ethics, ministry formation and community-health work. His career includes Fordham moral-theology teaching and parish ministry. He earned a Doctor of Sacred Theology at Pontifical Gregorian University. The ministry’s2004 joining date predates CommonSpirit’s2019 operational formation.

Thomas McGinn leads clinical services, physician enterprise, quality and research partnerships at CommonSpirit. A practising internist and clinical researcher, he previously held Northwell leadership roles. His education includes SUNY Downstate medicine and Columbia public health; he teaches at Baylor and Creighton.

Wright Lassiter III leads CommonSpirit Health as president and CEO and also heads its foundation. Previously he led Henry Ford Health and Alameda Health System. His leadership includes responsible clinical AI adoption and a National Academy of Medicine patient-safety initiative.

Fayika Farhat Nova is listed on Parkview’s current Health Services and Informatics Research team. Supervisor and Research Scientist Education Doctor of Philosophy, Computer Science, Marquette University, Milwaukee, Wisconsin Master of Science, Computing, Marquette University, Milwaukee, Wisconsin Bachelor of Science, Computer Science/Information and Communication Technology, Asian University for Women, Chittagong, Bangladesh Curriculum Vitae Google Scholar profile Active projects CCBHC-IA: Reimagining Mental Health Care Community Health Needs Assessment Conversation Agents/AI Chatbots COVID-19 Long-Haul Project Digital Self-Harm Completed projects Cyberbullying

Jessica Pater is listed on Parkview’s current Health Services and Informatics Research team. Manager and Senior Research Scientist Education Doctor of Philosophy, Human Centered Computing, Georgia Institute of Technology, Atlanta, Georgia Master of Science, International Affairs, Georgia Institute of Technology, Atlanta, Georgia Bachelor of Science, International Affairs, Georgia Institute of Technology, Atlanta, Georgia Curriculum Vitae Google Scholar profile Active projects Care PLUS Conversation Agents/AI Chatbots COVID-19 Health System and Community Support COVID-19 Long-Haul Project COVID-19 Surge Modeling Digital Self-Harm Healthy Digital Habits in Parents of Infants Completed projects Building Mental Health Resources to Inform Families Using Digital Guidance and Education (BRIDGE) Cyberbullying Digital Social Re-entry Opioid Use Disorder Treatment Modeling Telemental Health for Youth

Leah Nambajimana is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead II Education Bachelor of Science, Human Nutrition, Case Western Reserve University, Cleveland, Ohio MPH, Ohio University, Athens, Ohio Epidemiology Certificate, Ohio University, Athens, Ohio Curriculum Vitae LinkedIn profile

Vaibhavi Mone is listed on Parkview’s current Health Services and Informatics Research team. Research Scientist Education Doctor of Philosophy, Health Services Research Administration and Policy, University of Nebraska Medical Center, Omaha, Nebraska Master of Public Health, Epidemiology, Drexel University, Philadelphia, Pennsylvania Bachelor of Dental Surgery, Devi Ahilya University, India Curriculum Vitae Google Scholar profile Active projects Community Health Needs Assessment

Alyssa McKinley is listed on Parkview’s current Health Services and Informatics Research team. Research Assistant Education Bachelor of Science, Psychology, Purdue University, Fort Wayne, Indiana Curriculum Vitae Active projects CCBHC-IA: Reimagining Mental Health Care Community Health Needs Assessment

Brandon McDaniel is listed on Parkview’s current Health Services and Informatics Research team. Senior Research Scientist Education Doctor of Philosophy, Human Development and Family Studies, The Pennsylvania State University, University Park, Pennsylvania Master of Science, Human Development and Family Studies, The Pennsylvania State University, University Park, Pennsylvania Bachelor of Science, Philosophy, Brigham Young University, Provo, Utah Curriculum Vitae Google Scholar profile Active projects Falls Scale for Inpatient Care Healthy Digital Habits in Parents of Infants Maternal Technology Use and Infant Self-Regulation Phone Use Efficacy Scale Development Project EMBRACE Safety PIN (Protecting Indiana's Newborns) Completed projects Assessing Clinical Outcomes in Major Depressive Disorder Healthy Digital Habits - School Devices

Caralyn Logan Delaney is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead I Education Bachelor of Science, Biology and Psychology, Roger Williams University Curriculum Vitae Active projects COVID-19 Health System and Community Support COVID-19 Long-Haul Project Digital Self-Harm Maternal Technology Use and Infant Self-Regulation Completed projects Cyberbullying Food Assistance and Support Team Program Evaluation Social Determinants of Health

Hung-Yeh Lin is listed on Parkview’s current Health Services and Informatics Research team. User Experience Research Specialist I Education Master of Science, Human-Computer Interaction, Georgia Institute of Technology, Atlanta, Georgia Bachelor of Science, Chemical Engineering, National Taiwan University, Taipei, Taiwan Curriculum Vitae Google Scholar profile Active projects Guideline-Directed Medical Therapy for Heart Failure Recommendations for Sharing CIED Data with Patients Completed projects Social Determinants of Health TytoCare Pilot Usability and Acceptance of Patient Check-in Kiosks Usability of a Wound Compression Sensing Device Among Wound Care Staff Use of Technology to Support Patient Reported Outcomes in Palliative Oncology

Kristina Launer is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead I Education Bachelor of Arts, Anthropology & Sociology, Indiana University Fort Wayne, Fort Wayne, Indiana Curriculum Vitae Active projects Community Health Needs Assessment

Michelle Drouin is listed on Parkview’s current Health Services and Informatics Research team. Senior Research Scientist Education Doctor of Philosophy, Psychology, University of Oxford, Oxford, United Kingdom Bachelor of Arts, Psychology, Cornell University, Ithaca, New York Google Scholar profile Active projects Double Up SNAP Healthy Digital Habits in Parents of Infants Veggie Rx to HEAL Completed projects Certified Community Behavioral Health Clinic Expansion Grant Healthy Digital Habits - School Devices Oncology Patient Experience with Telehealth Opioid Use Disorder Mobile Response Team Opioid Use Disorder/Substance Use Disorder Care Continuum Initiative Rural Communities Opioid Response Program MAT Expansion Social Determinants of Health TytoCare Pilot

Mindy Flanagan is listed on Parkview’s current Health Services and Informatics Research team. Senior Research Scientist Education Doctor of Philosophy, Psychology, University of Missouri, Columbia, Missouri Master of Arts, Psychology, University of Missouri, Columbia, Missouri Bachelor of Arts, Psychology, Cornell College, Mt. Vernon, Iowa Curriculum Vitae Google Scholar profile Active projects Care PLUS Community Health Needs Assessment Guideline-Directed Medical Therapy for Heart Failure Recommendations for Sharing CIED Data with Patients Safety PIN (Protecting Indiana's Newborns) Completed projects Certified Community Behavioral Health Clinic Expansion Grant Cyberbullying Food Assistance and Support Team Program Evaluation Medication Adherence for AFib Patients Oncology Patient Experience with Telehealth Parkview Perinatal Center Data Review Rural Communities Opioid Response Program MAT Expansion Social Determinants of Health Telemental Health for Youth TytoCare Pilot Usability and Acceptance of Patient Check-in Kiosks

Amanda Coupe is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead I Education Master of Arts, Communication, University of Illinois, Chicago, Illinois (Expected 2025) Bachelor of Arts, Psychology, Purdue University, Fort Wayne, Indiana Curriculum Vitae Google Scholar profile Active projects CCBHC-IA: Reimagining Mental Health Care COVID-19 Long-Haul Project Digital Self-Harm Guideline Directed Medical Therapy for Heart Failure Medication Adherence for AFib Patients Recommendations for Sharing CIED Data with Patients Safety PIN (Protecting Indiana's Newborns) Completed projects Certified Community Behavioral Health Clinic Expansion Grant Telemental Health for Youth Use of Technology to Support Patient Reported Outcomes in Palliative Oncology

Jamie Berndt is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead II Education Bachelor of Science, Nursing, Western Governors University, Millcreek, Utah Associate of Science, Nursing, Ivy Tech Community College, Fort Wayne, Indiana Licensed Practical Nurse, Ivy Tech Community College, Fort Wayne, Indiana Curriculum Vitae

Jeanne Carroll is listed on Parkview’s current Health Services and Informatics Research team. Research Project Lead II Education Bachelor of Arts, Psychology, Huntington University, Huntington, Indiana Associate of Science, Nursing, University of St. Francis, Fort Wayne, Indiana Curriculum Vitae Google Scholar profile Active projects Community Health Needs Assessment COVID-19 Health System and Community Support COVID-19 Long-Haul Project Diabetes Care Direct Falls Scale for Inpatient Care Guideline-Directed Medical Therapy for Heart Failure Recommendations for Sharing CIED Data with Patients Completed projects Assessing Clinical Outcomes in Major Depressive Disorder Rural Communities Opioid Response Program (RCORP) Implementation Rural Communities Opioid Response Program MAT Expansion

Christopher Becker is listed on Parkview’s current Health Services and Informatics Research team. Research Software Engineer I Education Bachelor of Science, Computer Science, Purdue University, Fort Wayne, Indiana Curriculum Vitae

Abhinay Balasani is listed on Parkview’s current Health Services and Informatics Research team. Research Software Engineer I Education Master of Science, Computer Science, Purdue University, Fort Wayne, Indiana Bachelor of Technology, Electronics and Communication Engineering, VNR Vignana Jyothi Institute of Engineering and Technology, Hyderabad, Telangana, India Curriculum Vitae Google Scholar profile

Since joining Parkview Health in 2000, Dena Jacquay has served in several leadership roles, supporting administrative services and driving the health system’s culture, both within Parkview and in the communities Parkview serves. As chief administrative officer, Jacquay is responsible for key strategies that support the success of Parkview, such as information services, service excellence, community health and equity, and talent attraction, retention, and development. She is also responsible for leading the philanthropic efforts of the Parkview Health Foundation and overseeing many of Parkview’s administrative and support services, including Public Safety, Supply Chain, Marketing and Communications, Human Resources, Facilities Engineering, Nutrition Services, Education Services, and Environmental Services. Jacquay serves on several nonprofit community boards, including Ascend Indiana, Indiana Tech, the Northeast Indiana Regional Partnership, and Park Center. She is also a member of the Parkview Field Advisory Board. Jacquay was previously on boards for Easterseals Northern Indiana, Love Fort Wayne, TROY School, Blessings in a Backpack, and Early Childhood Alliance. She has also served more than 20 years as a community volunteer with the Allen County Public Library’s Audio Reading Service, which allows the visually impaired to hear the written word. Jacquay has a bachelor’s degree in organizational leadership and supervision from Purdue University and a master’s degree in business administration from Western Governors University.

Juli Johnson joined Parkview Health in 2004 and has served in a variety of administrative and clinical leadership roles. As chief nursing and healthcare markets executive, Johnson leads Parkview’s core markets and facilities across 22 counties in northern Indiana and northwest Ohio, including all nursing and clinical departments, such as Lab, Diagnostic Imaging, Pharmacy, Therapies, Sleep Medicine, and Cardiopulmonary. Strongly rooted in the community, Johnson serves on the boards of directors for Erin’s House for Grieving Children and Bippus State Bank. She is also a member of the Indiana University Fort Wayne Advisory Board. She previously served on the boards of directors for United Way of Huntington County and the Boys & Girls Clubs of Huntington County. Johnson received her bachelor of science in nursing from Indiana University in Bloomington, and her master of science in nursing from Western Governors University. She holds membership in the American College of Healthcare Executives, the American Nurses Association, the Northeast Indiana Organization for Nursing Leadership, and the Indiana Organization for Nursing Leadership.

Rich Church joined Parkview Health as chief strategy officer in April 2022. He is responsible for developing and optimizing Parkview’s growth and strategic priorities. As Parkview’s senior strategy leader, Church oversees the health system’s growth and integration initiatives in its core and emerging markets. He also leads Parkview Employer Solutions, asset strategy, government relations, financial decision support, and business intelligence. Prior to joining Parkview, he was a practicing attorney for 22 years and the co-leader of K&L Gates LLP’s global healthcare law and FDA practice. In that role, he worked closely with Parkview Health, along with other leading health systems and academic medical centers, as well as healthcare disruptors and startups, in implementing strategic initiatives and accelerating organizational performance. Church also previously taught medical ethics and religion at Wingate University. Church holds a bachelor of arts from Calvin College, a juris doctor from the Duke University School of Law, and a master of arts and a doctorate from Duke University in religion, with a specialization in theological ethics.

Ray Dusman, MD, joined Parkview Health in 2010 as a member of Fort Wayne Cardiology, where he served as a cardiologist. He became chief physician executive in 2013 and was instrumental in helping to build Parkview Physicians Group, substantially growing its staff of physicians and advanced practice providers. In his current role, he provides executive oversight for all clinical care delivery. This includes physician leadership within hospitals, service lines, and institutes, as well as safety and quality, physician enterprise, and Graduate Medical Education. Dr. Dusman currently serves as vice chairman of the Parkview Health Board of Directors and previously served on the boards of Erin’s House for Grieving Children, the Fort Wayne Philharmonic, the YMCA of Greater Fort Wayne, and the University of Saint Francis. Dr. Dusman has a master’s degree in business administration from the University of Notre Dame. He earned a medical degree at Rutgers New Jersey Medical School, and is board certified in internal medicine and cardiology.

Rick Henvey joined Parkview Health in 2006 and became chief executive officer in January 2023. Henvey’s leadership has been the driving force behind the health system’s continued growth. Parkview remains the region’s largest employer with more 17,500 co-workers. Under Henvey’s leadership, Parkview has consistently received national accolades. In 2025 Parkview was named a top five Most Loved Workplace in the nation by The Wall Street Journal, was named one of America’s Best-in-State Employers by Forbes, and won NRC Health’s Excellence in Experience Management Award—marking the third consecutive year of Parkview receiving national recognition from NRC Health. The health system also continues to consistently receive top safety grades from the Leapfrog Group. Heavily engaged in the community, Henvey serves on several boards of directors throughout the region, including Trine University, the Boys & Girls Clubs of Northeast Indiana, and the Central Indiana Corporate Partnership. His previous board service includes the Indiana Chamber, the Fort Wayne Children’s Zoo, the Fort Wayne Civic Theatre, Erin’s House for Grieving Children (board chair), the Northeast Indiana Innovation Center (board chair), and the Honeywell Foundation. Henvey has a bachelor’s degree in business administration and a master’s degree in management from Southern Nazarene University.

Parkview Health is a community-owned, nonprofit healthcare system serving Indiana and northwest Ohio. Its 2026 institutional factsheet identifies Parkview Health System Inc., incorporated in May 1995, as a 501(c)(3) organization. Its clinical roots extend to Fort Wayne City Hospital in 1878. The current system leadership directory describes 15 hospitals, more than 1,400 providers and more than 300 locations; the factsheet reports more than 17,500 employees and separately lists hospital facilities. This Indiana institution is distinct from Colorado’s Parkview Medical Center and unrelated investment firms. The Parkview Mirro Center for Research and Innovation supports clinical research, simulation, precision and genomic medicine, health informatics and healthcare technology commercialization. Its Health Services and Informatics Research team brings together data scientists, software engineers, psychologists, epidemiologists, human-computer interaction researchers and clinical project leaders. Projects cover digital health, behavioral and mental health, population health and patient-centered technology. Mirro is an institutional research and innovation center, rather than a separately established venture fund manager. Parkview Health is a named institutional participant in NeuroBell’s June 2026 financing, confirmed by University College Cork. NeuroBell develops neonatal brain-monitoring and AI technology. The announcement identifies Parkview Health in the United States without specifying a contracting subsidiary, investment vehicle or individual ticket. This institutional participation does not establish clinical device approval. The MedTech Global Gateway, operated with the Northeast Indiana Regional Partnership and Indiana Economic Development Corporation, helps international innovators with US market entry, clinical and regulatory connections, product usability and commercialization. Parkview’s Global Innovation Competition and community grants are separate programmes; prize ceilings, potential pilots and grant limits are not private fund closes or evidence of paid equity investments. A December 2025 partnership with Notre Dame and the 1842 Fund aims to create up to two AI businesses addressing rural healthcare in 2026. The announcement attributes initial investment to the external 1842 Fund, powered by Alloy Partners, rather than to a Parkview-owned fund. Published leadership includes the six current system executives, the 23-person Mirro informatics research directory, board chair Dan Starr and community-impact leader Sarah GiaQuinta. Rick Henvey is CEO; Ray Dusman leads the physician and clinical enterprise and serves as board vice chair. Research-team roles are scoped to Mirro and do not imply individual investment authority. Exact private financing allocations, a comprehensive current board roster and any independently managed Parkview venture fund remain unverified.

KAHR Bio is an Israeli clinical-stage biotechnology company developing multifunctional biologic immunotherapies for cancer. Its lead investigational drug, DSP107, is a bispecific fusion protein that binds CD47 on tumour cells and engages the 4-1BB costimulatory pathway to activate T cells, while also seeking to reverse CD47-mediated suppression of innate immunity. Development currently focuses on advanced microsatellite-stable colorectal cancer, including combination treatment with the anti-PD-L1 medicine atezolizumab. A randomized Phase IIb study compares that combination with fruquintinib; ClinicalTrials.gov lists the study as recruiting, sponsored by the separate Australian entity Kahr Bio Australia Pty Ltd. Earlier clinical programs investigated other solid tumours and myelodysplastic syndromes. KAHR retains global rights to DSP107 and describes a clinical collaboration and atezolizumab supply agreement with Roche. DSP107 is investigational: an IND clearance permits clinical research and does not constitute marketing approval. The company’s comparative survival claims require confirmation through controlled trials.

Adam Foley-Comer is published as KAHR Bio’s chief medical officer. Its leadership card lists prior affiliations with Roche, BioLineRx, Quintiles, Immune Pharmaceuticals. These are career-background claims, not simultaneous KAHR duties.

Aron Knickerbocker is published as KAHR Bio’s board chairman. Its leadership card lists prior affiliations with Aulos, RayzeBio, FivePrime, Genentech, Amgen. These are career-background claims, not simultaneous KAHR duties.

Ayelet Chajut is published as KAHR Bio’s chief technology officer. Its leadership card lists prior affiliations with Pluristem, Rosetta Genomics, Quark Pharmaceuticals, Compugen. These are career-background claims, not simultaneous KAHR duties.

Tomer Cohen is published as KAHR Bio’s chief financial officer and chief business officer. Its leadership card lists prior affiliations with Locust Walk, Barclays, Goldman Sachs. These are career-background claims, not simultaneous KAHR duties.

Yaron Pereg is published as KAHR Bio’s chief executive officer. Its leadership card lists prior affiliations with Genentech, BioLineRx, Cellect. These are career-background claims, not simultaneous KAHR duties.

Sophie Papa holds the source-published role of Advisor within RA Capital Management’s Raven group. Published academic qualifications: FRCP PhD. Universities identified in the own biography: St John’s College, University of Oxford, Imperial College London. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Joel Barrish holds the source-published role of Advisor within RA Capital Management’s Raven group. Published academic qualifications: PhD, BS. Universities identified in the own biography: Columbia University, University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Sadik Kassim holds the source-published role of Advisor within RA Capital Management’s Raven group. Published academic qualifications: PhD, BS. Universities identified in the own biography: Tulane University, Louisiana State University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Cosmas Giallourakis holds the source-published role of Venture Partner - Consultant within RA Capital Management’s Raven group. Published academic qualifications: MD , BS. Universities identified in the own biography: Massachusetts Institute of Technology, Rutgers. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Dan Grau holds the source-published role of Advisor within RA Capital Management’s Raven group. Published academic qualifications: MPhil, MA , MAR , BA. Universities identified in the own biography: Davidson College, Yale University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Habib Dable holds the source-published role of Advisor within RA Capital Management’s Raven group. Published academic qualifications: MBA , BBA. Universities identified in the own biography: University of New Brunswick, Stanford University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Huiyuan Zhang holds the source-published role of Senior Associate within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Harvard University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jill Wykosky holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Pittsburgh, Wake Forest. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Paul Yaworsky holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BSc, PhD. Universities identified in the own biography: University of Toronto; Mayo Clinic. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Aarya Venkat holds the source-published role of Senior Scientist, Protein Design & Modeling within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Georgia. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Adam Travis holds the source-published role of Vice President, Corporate Development within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: MD. Universities identified in the own biography: Vanderbilt University, University of Louisville School of Medicine. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Alison Tisdale holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Massachusetts Institute of Technology. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

David Weinstock holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MD. Universities identified in the own biography: University of Chicago, George Washington University, Harvard University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Iris Wang holds the source-published role of Director, Talent Acquisition within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: BA , MS. Universities identified in the own biography: University of International Business and Economics, Simmons School of Management. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Maryann Vigliotta holds the source-published role of Vice President of Operations and Human Resources within RA Capital Management’s Raven group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: Northeastern University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Mindy Tam holds the source-published role of Executive Assistant within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: Mount Ida College. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Tammy Toole holds the source-published role of Vice President, Regulatory Strategy, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BS , JD. Universities identified in the own biography: Villanova University and The Catholic University of America. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Ally Roa holds the source-published role of Executive Assistant within RA Capital Management’s Raven group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: Union College. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Bimal Shah holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: MD , MBA. Universities identified in the own biography: University of North Carolina Chapel Hill, Duke University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Camille Snyder holds the source-published role of Associate Director, Patient Recruitment & Engagement, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: St. John Fisher College. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Caroline Seroussi holds the source-published role of Executive Assistant within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BA , MA. Universities identified in the own biography: Brown University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Gerald Sewack holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Harvard Medical School. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Leocadia Ruiz holds the source-published role of Vice President, CMC, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MS. Universities identified in the own biography: Northwestern University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Prithviraj Singha Roy holds the source-published role of Vice President, Corporate Development and Health Services within RA Capital Management’s Raven group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: Duke University, Northwestern University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Anish More holds the source-published role of Vice President, Healthcare Services within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: Tuck School of Business at Dartmouth, Michigan State University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Anish Suri holds the source-published role of Consulting Venture Partner within RA Capital Management’s Raven group. Published academic qualifications: Washington. Universities identified in the own biography: PhD. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Elnaz Menhaji-Klotz holds the source-published role of Senior Director, Corporate Development within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Yale University, Barnard College. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jacob Oppenheim holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Princeton University, Rockefeller University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Kat Riesen holds the source-published role of Senior Vice President, Finance within RA Capital Management’s Raven group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: University of Minnesota Carlson School of Management. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Robert Nicol holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2022; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Houston, Massachusetts Institute of Technology. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Sara Pacheco holds the source-published role of Senior Director of Finance within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: University of California Santa Barbara. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Sarah Piantedosi holds the source-published role of Senior Director, Development Strategy & Operations, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: Fairfield University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Camille Landis holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: University of St. Thomas, University of California Berkeley. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Charlotte McDonagh holds the source-published role of Entrepreneur In Residence within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Leicester, UK. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jen Koblan holds the source-published role of Head of Strategic Alliances, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BA , Masters Human Resource Development. Universities identified in the own biography: Clemson University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Kinsey Medlin holds the source-published role of Manager, Patient Recruitment & Insights, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MPH. Universities identified in the own biography: Yale. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Laura Kolstad holds the source-published role of Senior Associate within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MBA , BS. Universities identified in the own biography: Dartmouth, Bucknell University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Renat Last holds the source-published role of Director, Patient Engagement & Insights, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MPH. Universities identified in the own biography: Stony Brook Unviersity, City University of New York School of Public Health. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Sarah Mahar holds the source-published role of Project Manager, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MPH. Universities identified in the own biography: Boston University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Stacey Lynch holds the source-published role of Talent Operations Business Partner within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: Western Connecticut State University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Alex Hsu holds the source-published role of Senior Director, Corporate Development and Health Services within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: University of Michigan, University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Allison Harrigan holds the source-published role of Senior Director, Portfolio Strategy & Program Management within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: Georgetown University, Massachusetts Institute of Technology Sloan School of Management. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Dann Huh holds the source-published role of Senior Director, Genomic Target Validation within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Seoul National University, Harvard University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jaclyn Henderson holds the source-published role of Entrepreneur in Residence within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Edinburgh. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Jonathan Hill holds the source-published role of Entrepreneur In Residence within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Western Ontario. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Maria-Louisa Izamis holds the source-published role of Senior Director Corporate Development within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: MIT. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Sonia Kartha holds the source-published role of Director, Corporate Development within RA Capital Management’s Raven group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Varandt Khodaverdian holds the source-published role of Raven Senior Associate within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Tufts Univeristy, Case Western Reserve University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Chris Halpin holds the source-published role of Director, Operations and Lab Management within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: Suffolk University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Gunnar Esiason holds the source-published role of Vice President, Patient Strategy & Innovation, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2023; a precise appointment day is not available. Published academic qualifications: MBA , MPH. Universities identified in the own biography: Boston College, Tuck School of Business at Dartmouth College, Dartmouth Institute for Health Policy & Clinical Practice. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Joseph Flanagan holds the source-published role of Senior Director, Data Product within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: University of Massachusetts. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Kelly Ford holds the source-published role of Executive Assistant within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: Plymouth State University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Milind Deshpande holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: Ohio University. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Nithya Desikan holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BS. Universities identified in the own biography: University of Florida. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Paras Doshi holds the source-published role of Senior Director, Corporate Development within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: Kellogg School of Management. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Ramin Farzaneh-Far holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: MA , MD , MAS. Universities identified in the own biography: University of Cambridge, University College London, University of California an Francisco. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Cassie Bryan holds the source-published role of Senior Director, Protein Design within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Washington. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Emilie Castonguay holds the source-published role of Senior Director, Corporate Development within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Laval, University of Montréal, University of Edinburgh. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Fanny Cavalié holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: MBA. Universities identified in the own biography: HEC Paris. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Kara Coluccio holds the source-published role of Head of Talent Acquisition & Strategy within RA Capital Management’s Raven group. The individual directory reports joining in2025; a precise appointment day is not available. Published academic qualifications: MS. Universities identified in the own biography: University of Pennsylvania. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Karen Campbell holds the source-published role of Vice President of Development Strategy & Operations, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: BA. Universities identified in the own biography: University Of New Hampshire. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Katie Dahlstrom holds the source-published role of Senior Vice President, Development Strategy and Operations, Blackbird within RA Capital Management’s Raven group. The individual directory reports joining in2024; a precise appointment day is not available. Published academic qualifications: MA. Universities identified in the own biography: Stonehill College, Boston University Medical School. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.

Kleem Chaudhary holds the source-published role of Venture Partner within RA Capital Management’s Raven group. The individual directory reports joining in2026; a precise appointment day is not available. Published academic qualifications: PhD. Universities identified in the own biography: University of Winnipeg, University of North Carolina. This affiliation supports the firm’s healthcare research, investment, company-building, planetary-health or operational work according to the stated group. Published adviser and venture-partner titles retain their scope and do not imply employment or a general-partner appointment. Specific personal checks are not inferred from affiliation.